-
30 April 2025 07:01:47
- Source: Sharecast

Barclays PLC
Q1 2025 Results Announcement
31 March 2025
Notes
The terms Barclays and Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the three months ended 31 March 2025 to the corresponding three months of 2024 and balance sheet analysis as at 31 March 2025 with comparatives relating to 31 December 2024 and 31 March 2024. The abbreviations '£m' and '£bn' represent millions and thousands of millions of Pounds Sterling respectively; the abbreviations '$m' and '$bn' represent millions and thousands of millions of US Dollars respectively; and the abbreviations '€m' and '€bn' represent millions and thousands of millions of Euros respectively.
There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment and modifications. Reported numbers reflect best estimates and judgements at the given point in time.
Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS) are explained in the results glossary, which can be accessed at home.barclays/investor-relations.
The information in this announcement, which was approved by the Board of Directors on 29 April 2025, does not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2024, which contain an unmodified audit report under Section 495 of the Companies Act 2006 (which does not make any statements under Section 498 of the Companies Act 2006) will be delivered to the Registrar of Companies in accordance with Section 441 of the Companies Act 2006.
These results will be furnished on Form 6-K to the US Securities and Exchange Commission (SEC) as soon as practicable following publication of this document. Once furnished to the SEC, a copy of the Form 6-K will be available from the SEC's website at www.sec.gov.
Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal roadshows and other ad hoc meetings. Consistent with its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other matters relating to the Group.
Non-IFRS performance measures
Barclays' management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by Barclays' management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well. Refer to the appendix on pages 41 to 48 for definitions and calculations of non-IFRS performance measures included throughout this document, and reconciliations to the most directly comparable IFRS measures.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. Forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as 'may', 'will', 'seek', 'continue', 'aim', 'anticipate', 'target', 'projected', 'expect', 'estimate', 'intend', 'plan', 'goal', 'believe', 'achieve' or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by directors, officers and employees of the Group (including during management presentations) in connection with this document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group's future financial position, business strategy, income levels, costs, assets and liabilities, impairment charges, provisions, capital leverage and other regulatory ratios, capital distributions (including policy on dividends and share buybacks), return on tangible equity, projected levels of growth in banking and financial markets, industry trends, any commitments and targets (including environmental, social and governance ("ESG") commitments and targets), plans and objectives for future operations, International Financial Reporting Standards ("IFRS") and other statements that are not historical or current facts. By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances. Forward-looking statements speak only as at the date on which they are made. Forward-looking statements may be affected by a number of factors, including, without limitation: changes in legislation, regulations, governmental and regulatory policies, expectations and actions, voluntary codes of practices and the interpretation thereof, changes in IFRS and other accounting standards, including practices with regard to the interpretation and application thereof and emerging and developing sustainability reporting standards (including emissions accounting methodologies); the outcome of current and future legal proceedings and regulatory investigations; the Group's ability along with governments and other stakeholders to measure, manage and mitigate the impacts of climate change effectively or navigate inconsistencies and conflicts in the manner in which climate policy is implemented in the regions where the Group operates, including as a result of the adoption of anti-ESG rules and regulations, or other forms of governmental and regulatory action against ESG policies; environmental, social and geopolitical risks and incidents and similar events beyond the Group's control; financial crime; the impact of competition in the banking and financial services industry; capital, liquidity, leverage and other regulatory rules and requirements applicable to past, current and future periods; UK, US, Eurozone and global macroeconomic and business conditions, including inflation; volatility in credit and capital markets; market related risks such as changes in interest rates and foreign exchange rates; reforms to benchmark interest rates and indices; higher or lower asset valuations; changes in credit ratings of any entity within the Group or any securities issued by it; changes in counterparty risk; changes in consumer behaviour; changes in trade policy, including the imposition of tariffs or other protectionist measures; the direct and indirect consequences of the conflicts in Ukraine and the Middle East on European and global macroeconomic conditions, political stability and financial markets; political elections, including the impact of the US elections in 2024 and subsequent changes in legislation and policy; developments in the UK's relationship with the European Union; the risk of cyberattacks, information or security breaches, technology failures or operational disruptions and any subsequent impact on the Group's reputation, business or operations; the Group's ability to access funding; and the success of acquisitions (including the acquisition of Tesco Bank completed in November 2024), disposals, joint ventures and other strategic transactions. A number of these factors are beyond the Group's control. As a result, the Group's actual financial position, results, financial and non-financial metrics or performance measures or its ability to meet commitments and targets may differ materially from the statements or guidance set forth in the Group's forward-looking statements. In setting its targets and outlook for the period 2024-2026, Barclays has made certain assumptions about the macroeconomic environment, including, without limitation, inflation, interest and unemployment rates, the different markets and competitive conditions in which Barclays operates, and its ability to grow certain businesses and achieve costs savings and other structural actions. Additional risks and factors which may impact the Group's future financial condition and performance are identified in Barclays PLC's filings with the US Securities and Exchange Commission ("SEC") (including, without limitation, Barclays PLC's Annual Report on Form 20-F for the financial year ended 31 December 2024), which are available on the SEC's website at www.sec.gov.
Subject to Barclays PLC's obligations under the applicable laws and regulations of any relevant jurisdiction (including, without limitation, the UK and the US) in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Performance Highlights
In Q125 Barclays delivered a return on tangible equity (RoTE) of 14.0%, and is on track to deliver 2025 guidance and 2026 targets
C. S. Venkatakrishnan, Group Chief Executive, commented
"I am very pleased with our performance in Q125, which represents another strong quarter of execution. Compared to Q124, we grew our top line income by 11%, our profit before tax by 19%, our earnings per share (EPS) by 26%, and delivered a Group RoTE of 14.0%. We also ended the quarter with a Common Equity Tier 1 (CET1) ratio of 13.9% and a liquidity coverage ratio (LCR) of 175%.
Our high quality, diversified businesses, together with proactive risk, capital and liquidity management and a robust balance sheet, position us well to support our customers and clients and deliver strong risk-adjusted returns in a wide range of macroeconomic scenarios. We remain committed to and confident in delivering our previously announced financial and distribution targets for 2025 and 2026."
• Q125 Group statutory RoTE of 14.0% with EPS improving to 13.0p (Q124: 10.3p)
• Guidance for 2025 Group NII excluding Barclays Investment Bank and Head Office increased from c.£12.2bn to greater than £12.5bn. Within this, Barclays UK NII guidance increased from c.£7.4bn to greater than £7.6bn
• Q125 Group cost: income ratio of 57% (FY25 guidance of c.61%)
- Delivered c.£150m of gross cost efficiency savings in Q125 (FY25 guidance of c.£0.5bn)
• Q125 loan loss rate (LLR) of 61bps, including a net £74m post model adjustment for elevated US macroeconomic uncertainty
- Trends across our portfolios do not currently show signs of deterioration
- Delinquencies remained broadly stable for US cards and UK cards:
- US cards 30 and 90 day arrears were 3.0%1 (Q124: 3.1%) and 1.6%1 (Q124: 1.7%) respectively
- UK cards 30 and 90 day arrears were 0.7%2 (Q124: 0.9%) and 0.2%2 (Q124: 0.2%) respectively
• Strong balance sheet with CET1 ratio of 13.9%, at upper end of target range of 13-14%
• Tangible net asset value (TNAV) per share of 372p (December 2024: 357p)
• Completed sale of German consumer finance business, resulting in a c.10bps CET1 ratio increase in Q125
• Announced long-term strategic partnership for Payment Acceptance business
Key financial metrics:
|
Income |
Profit before tax |
Attributable profit |
Cost: income ratio |
LLR |
RoTE |
EPS |
TNAV per share |
CET1 ratio |
Q125 |
£7.7bn |
£2.7bn |
£1.9bn |
57% |
61bps |
14.0% |
13.0p |
372p |
13.9% |
Q125 Performance highlights:
• Group RoTE was 14.0% (Q124: 12.3%) with profit before tax of £2.7bn (Q124: £2.3bn)
• Group income of £7.7bn was up 11% year-on-year, with Group NII excluding Barclays Investment Bank and Head Office of £3.0bn, up 13% year-on-year
- Barclays UK income increased 14%, driven by higher structural hedge income and the acquisition of Tesco Bank
- Barclays UK Corporate Bank (UKCB) income increased 12%, reflecting higher average deposit balances
- Barclays Private Bank and Wealth Management (PBWM) income increased 12%, reflecting higher client balances and transactional activity
- Barclays Investment Bank (IB) income increased 16%, including a 21% increase in FICC in Global Markets and higher Investment Banking income
- Barclays US Consumer Bank (USCB) income increased 1% reflecting card balance growth
• Group total operating expenses were £4.4bn, up 5% year-on-year
- Group operating costs increased 7% to £4.3bn, reflecting Tesco Bank costs, further investment spend and business growth, inflation and the c.£50m expense for the employee share grant announced at FY24 Results, partially offset by c.£150m of cost efficiency savings
• Credit impairment charges were £0.6bn (Q124: £0.5bn) with an LLR of 61bps (Q124: 51bps)
• CET1 ratio of 13.9% (December 2024: 13.6%), with risk weighted assets (RWAs) of £351.3bn (December 2024: £358.1bn) and TNAV per share of 372p (December 2024: 357p)
1 |
Including a co-branded cards portfolio classified as assets held for sale. |
2 |
Excludes Tesco Bank to aid comparability year-on-year. |
Group financial guidance and targets1:
2025 guidance
• Returns: RoTE of c.11%
• Capital returns: progressive increase in total capital returns versus 2024
• Income: Group NII excluding IB and Head Office of greater than £12.5bn, of which Barclays UK NII of greater than £7.6bn
• Costs: Group cost: income ratio of c.61%. This includes total gross efficiency savings of c.£0.5bn in 2025
• Impairment: LLR of 50-60bps through the cycle
• Capital: CET1 ratio target range of 13-14%
2026 targets
• Returns: RoTE of greater than 12%
• Capital returns: plan to return at least £10bn of capital to shareholders between 2024 and 2026, through dividends and share buybacks, with a continued preference for buybacks
- Plan to keep total dividend stable at 2023 level in absolute terms, with progressive dividend per share growth driven through share count reduction as a result of increased share buybacks
- Dividends will continue to be paid semi-annually. This multi-year plan is subject to supervisory and Board approval, anticipated financial performance and our published CET1 ratio target range of 13-14%
• Income: Group total income of c.£30bn
• Costs: Group cost: income ratio of high 50s in percentage terms, implying Group total operating expenses of c.£17bn, based on targeted Group total income of c.£30bn. Cost target includes total gross efficiency savings of c.£2bn by 2026
• Impairment: expect an LLR of 50-60bps through the cycle
• Capital: CET1 ratio target range of 13-14%
- Targeting IB RWAs of c.50% of Group RWAs in 2026
- Impact of regulatory change on RWAs in line with our prior guidance of c.£19-26bn
- c.£3-10bn RWAs from Basel 3.1, with implementation expected on 1 January 2027
- c.£16bn RWAs from USCB moving to an Internal Ratings Based (IRB) model, subject to model build and portfolio changes, implementation could be beyond 2026
- 0.1% increase in Pillar 2A from Q125 until model implementation
1 |
Our targets and guidance are based on management's current expectations as to the macroeconomic environment and the business and may be subject to change. |
Barclays Group results |
|
Three months ended |
||
|
|
31.03.25 |
31.03.24 |
|
|
|
£m |
£m |
% Change |
Barclays UK |
|
2,074 |
1,826 |
14 |
Barclays UK Corporate Bank |
|
484 |
434 |
12 |
Barclays Private Bank and Wealth Management |
|
349 |
312 |
12 |
Barclays Investment Bank |
|
3,873 |
3,328 |
16 |
Barclays US Consumer Bank |
|
864 |
859 |
1 |
Head Office |
|
65 |
194 |
(66) |
Total income |
|
7,709 |
6,953 |
11 |
Operating costs |
|
(4,258) |
(3,998) |
(7) |
UK regulatory levies |
|
(96) |
(120) |
20 |
Litigation and conduct |
|
(11) |
(57) |
81 |
Total operating expenses |
|
(4,365) |
(4,175) |
(5) |
Other net income |
|
18 |
12 |
50 |
Profit before impairment |
|
3,362 |
2,790 |
21 |
Credit impairment charges |
|
(643) |
(513) |
(25) |
Profit before tax |
|
2,719 |
2,277 |
19 |
Tax charge |
|
(621) |
(465) |
(34) |
Profit after tax |
|
2,098 |
1,812 |
16 |
Non-controlling interests |
|
(2) |
(3) |
33 |
Other equity instrument holders |
|
(232) |
(259) |
10 |
Attributable profit |
|
1,864 |
1,550 |
20 |
|
|
|
|
|
Performance measures |
|
|
|
|
Return on average tangible shareholders' equity |
|
14.0% |
12.3% |
|
Average tangible shareholders' equity (£bn) |
|
53.1 |
50.5 |
|
Cost: income ratio |
|
57% |
60% |
|
Loan loss rate (bps) |
|
61 |
51 |
|
Basic earnings per ordinary share |
|
13.0p |
10.3p |
|
Basic weighted average number of shares (m) |
|
14,314 |
14,983 |
(4) |
Period end number of shares (m) |
|
14,336 |
15,091 |
(5) |
Period end tangible shareholders' equity (£bn) |
|
53.4 |
50.6 |
|
|
As at 31.03.25 |
As at 31.12.24 |
As at 31.03.24 |
Balance sheet and capital management1 |
£bn |
£bn |
£bn |
Loans and advances at amortised cost |
419.4 |
414.5 |
397.9 |
Loans and advances at amortised cost impairment coverage ratio |
1.2% |
1.2% |
1.4% |
Total assets |
1,593.5 |
1,518.2 |
1,577.1 |
Deposits at amortised cost |
574.3 |
560.7 |
552.3 |
Tangible net asset value per share |
372p |
357p |
335p |
Common equity tier 1 ratio |
13.9% |
13.6% |
13.5% |
Common equity tier 1 capital |
48.8 |
48.6 |
47.1 |
Risk weighted assets |
351.3 |
358.1 |
349.6 |
UK leverage ratio |
5.0% |
5.0% |
4.9% |
UK leverage exposure |
1,252.8 |
1,206.5 |
1,226.5 |
|
|
|
|
Funding and liquidity |
|
|
|
Group liquidity pool (£bn) |
336.3 |
296.9 |
323.5 |
Liquidity coverage ratio2 |
175.3% |
172.4% |
163.2% |
Net stable funding ratio3 |
136.2% |
134.9% |
135.7% |
Loan: deposit ratio |
73% |
74% |
72% |
1 |
Refer to pages 33 to 37 for further information on how capital, RWAs and leverage are calculated. |
2 |
Represents average of the last 12 spot month end ratios. |
3 |
Represents average of the last four spot quarter end positions. |
Group Finance Director's Review
Q125 Group performance
• Barclays delivered a profit before tax of £2,719m (Q124: £2,277m), RoTE of 14.0% (Q124: 12.3%) and EPS of 13.0p (Q124: 10.3p)
• The Group has a diverse income profile across businesses and geographies including a significant presence in the US. The average GBP/USD exchange rate in Q125 was broadly the same as prior year. The strengthening of the spot GBP/USD exchange rate since December 20241 reduced the value of USD denominated assets and liabilities
• Group statutory income increased 11% to £7,709m (Q124: £6,953m), driven by higher structural hedge income, higher income in Global Markets, particularly in FICC, and Tesco Bank
• Group total operating expenses increased to £4,365m (Q124: £4,175m). Group operating costs increased 7% to £4,258m, reflecting Tesco Bank costs, further investment spend and business growth, inflation and the c.£50m expense for the employee share grant announced at FY24 Results, partially offset by c.£150m of cost efficiency savings
• Credit impairment charges increased to £643m (Q124: £513m), primarily driven by a post model adjustment of net £74m for elevated US macroeconomic uncertainty, and stage migration impact for Tesco Bank post day 1 acquisition. Total coverage ratio remains stable at 1.2% (December 2024: 1.2%)
• The effective tax rate (ETR) was 22.8% (Q124: 20.4%). The Q124 ETR was lower as a result of tax benefits in that period
• Attributable profit was £1,864m (Q124: £1,550m)
• Total assets increased to £1,593.5bn (December 2024: £1,518.2bn), driven by an increase in trading activity in IB and an increase in the liquidity pool from increased deposits and wholesale funding. This was partially offset by a reduction in derivatives
• TNAV per share increased to 372p (December 2024: 357p) including EPS of 13.0p. An increase in the cash flow hedging reserve was partially offset by a movement in the currency translation reserve
Group capital and leverage
• The CET1 ratio increased by c.30bps to 13.9% (December 2024: 13.6%) as CET1 capital increased by £0.2bn to £48.8bn and RWAs decreased by £6.8bn to £351.3bn:
- c.50bps increase from attributable profit
- c.40bps decrease driven by shareholder distributions including the £1.0bn share buyback announced with FY24 Results and an accrual towards the FY25 dividend
- c.10bps increase from other CET1 capital movements
- c.10bps increase as a result of a £3.7bn decrease in RWAs, excluding the impact of foreign exchange movements, primarily driven by the disposal of the German consumer finance business
- A £0.5bn decrease in CET1 capital due to a decrease in the currency translation reserve was broadly offset by a £3.1bn decrease in RWAs as a result of foreign exchange movements
• The UK leverage ratio remained stable at 5.0% (December 2024: 5.0%), as leverage exposure increased by £46.3bn to £1,252.8bn (December 2024: £1,206.5bn) partially offset by an increase in Tier 1 capital of £1.4bn. The increase in leverage exposure was largely driven by an increase in trading activity in IB
Group funding and liquidity
• The liquidity metrics remain well above regulatory requirements, underpinned by well-diversified sources of funding, a stable global deposit franchise and a highly liquid balance sheet
• The liquidity pool was £336.3bn, an increase of £39.4bn from December 2024 (£296.9bn). The increase in the liquidity pool was primarily driven by deposit growth in IB, UKCB and PBWM, and in term wholesale funding
• The average2 LCR increased to 175.3% (December 2024: 172.4%), equivalent to a surplus of £132.0bn (December 2024: £127.6bn)
• Total deposits increased by £13.6bn to £574.3bn (December 2024: £560.7bn), driven by inflows of customer deposits in IB, PBWM and UKCB
• The average3 Net Stable Funding Ratio (NSFR) was 136.2% (December 2024: 134.9%), which represents a £169.5bn surplus (December 2024: £162.9bn) above the 100% regulatory requirement
• Wholesale funding outstanding, excluding repurchase agreements, was £195.6bn (December 2024: £186.0bn)
• The Group issued £6.9bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC (the Parent company) in Q125. The Group has a strong MREL position with a ratio of 36.2%, which is in excess of the regulatory requirement of 30.7% plus a confidential, institution specific, PRA buffer
1 |
Refer to page 49 for more information on FX rates. |
2 |
Represents average of the last 12 spot month end ratios. |
3 |
Represents average of the last four spot quarter end ratios. |
Other matters
• Disposal of German consumer finance business: In Q125, Barclays Bank Ireland PLC announced the completion of the sale of its German consumer finance business to BAWAG P.S.K., a wholly owned subsidiary of BAWAG Group AG. The sale released c.£3.3bn of RWAs, increasing Barclays' CET1 ratio by c.10bps in Q125
• Long-term strategic partnership for Payment Acceptance business: On 17 April 2025, Barclays announced it had entered into a long-term strategic partnership with Brookfield Asset Management Ltd to grow and transform Barclays' Payment Acceptance business, previously referred to as the merchant acquiring business
Anna Cross, Group Finance Director
Results by Business
Barclays UK |
Three months ended |
||
|
31.03.25 |
31.03.24 |
|
Income statement information |
£m |
£m |
% Change |
Net interest income |
1,822 |
1,549 |
18 |
Net fee, commission and other income |
252 |
277 |
(9) |
Total income |
2,074 |
1,826 |
14 |
Operating costs |
(1,115) |
(1,007) |
(11) |
UK regulatory levies |
(43) |
(54) |
20 |
Litigation and conduct |
(2) |
(2) |
|
Total operating expenses |
(1,160) |
(1,063) |
(9) |
Other net income |
- |
- |
|
Profit before impairment |
914 |
763 |
20 |
Credit impairment charges |
(158) |
(58) |
|
Profit before tax |
756 |
705 |
7 |
Attributable profit |
510 |
479 |
6 |
|
|
|
|
Performance measures |
|
|
|
Return on average allocated tangible equity |
17.4% |
18.5% |
|
Average allocated tangible equity (£bn) |
11.7 |
10.4 |
|
Cost: income ratio |
56% |
58% |
|
Loan loss rate (bps) |
28 |
11 |
|
Net interest margin |
3.55% |
3.09% |
|
|
|
|
|
|
As at 31.03.25 |
As at 31.12.24 |
As at 31.03.24 |
Balance sheet information |
£bn |
£bn |
£bn |
Loans and advances to customers at amortised cost |
209.6 |
207.7 |
200.8 |
Total assets |
301.4 |
299.8 |
293.3 |
Customer deposits at amortised cost |
243.1 |
244.2 |
237.2 |
Loan: deposit ratio |
93% |
92% |
92% |
Risk weighted assets |
85.0 |
84.5 |
76.5 |
Period end allocated tangible equity |
11.8 |
11.6 |
10.7 |
Analysis of Barclays UK |
Three months ended |
||
31.03.25 |
31.03.24 |
|
|
Analysis of total income |
£m |
£m |
% Change |
Personal Banking1 |
1,348 |
1,128 |
20 |
Barclaycard Consumer UK |
225 |
229 |
(2) |
Business Banking |
501 |
469 |
7 |
Total income |
2,074 |
1,826 |
14 |
|
|
|
|
Analysis of credit impairment charges |
|
|
|
Personal Banking1 |
(107) |
(14) |
|
Barclaycard Consumer UK |
(38) |
(38) |
- |
Business Banking |
(13) |
(6) |
|
Total credit impairment charges |
(158) |
(58) |
|
|
|
|
|
|
As at 31.03.25 |
As at 31.12.24 |
As at 31.03.24 |
Analysis of loans and advances to customers at amortised cost |
£bn |
£bn |
£bn |
Personal Banking1 |
179.3 |
177.0 |
169.0 |
Barclaycard Consumer UK |
11.1 |
11.0 |
9.8 |
Business Banking |
19.2 |
19.7 |
22.0 |
Total loans and advances to customers at amortised cost |
209.6 |
207.7 |
200.8 |
|
|
|
|
Analysis of customer deposits at amortised cost |
|
|
|
Personal Banking1 |
190.8 |
191.4 |
183.4 |
Barclaycard Consumer UK |
- |
- |
- |
Business Banking |
52.3 |
52.8 |
53.8 |
Total customer deposits at amortised cost |
243.1 |
244.2 |
237.2 |
1 |
Following the completion of the acquisition on 1 November 2024, Tesco Bank is reported in Personal Banking. |
Barclays UK delivered a RoTE of 17.4% (Q124: 18.5%) supported by robust income, strong asset quality and disciplined cost management, with continued investment in delivering a simpler, better and more balanced retail bank.
Income statement - Q125 compared to Q124
• Profit before tax increased 7% to £756m
• Total income increased 14% to £2,074m. NII increased 18% to £1,822m, as continued structural hedge momentum and the impact from the acquisition of Tesco Bank was partially offset by adverse deposit dynamics, which stabilised through 2024, and mortgage margin compression. Net fee, commission and other income decreased 9% to £252m
• Total operating expenses increased 9% to £1,160m, driven by Tesco Bank costs and inflation. Ongoing efficiency savings continue to be reinvested, to drive sustainable improvement to the cost: income ratio
• Credit impairment charges were £158m (Q124: £58m), driven by stage migration impact for Tesco Bank post day 1 acquisition, consistent low delinquencies in UK cards and high quality mortgage lending portfolio. UK cards (excluding Tesco Bank) 30 and 90 day arrears remained low at 0.7% (Q124: 0.9%) and 0.2% (Q124: 0.2%) respectively. The UK cards total coverage ratio increased to 4.9% (December 2024: 4.8%) due to stage migration in Tesco Bank
Balance sheet - 31 March 2025 compared to 31 December 2024
• Loans and advances to customers at amortised cost increased by £1.9bn to £209.6bn, primarily driven by growth in mortgage lending, partially offset by continued repayment of government scheme lending in Business Banking
• Customer deposits at amortised cost decreased by £1.1bn to £243.1bn, driven by a reduction in retail savings and Business Banking current account balances due to seasonality. The loan: deposit ratio remained stable at 93% (December 2024: 92%)
• RWAs increased to £85.0bn (December 2024: £84.5bn) primarily due to mortgage lending growth
Barclays UK Corporate Bank |
Three months ended |
||
|
31.03.25 |
31.03.24 |
|
Income statement information |
£m |
£m |
% Change |
Net interest income |
342 |
277 |
23 |
Net fee, commission, trading and other income |
142 |
157 |
(10) |
Total income |
484 |
434 |
12 |
Operating costs |
(234) |
(221) |
(6) |
UK regulatory levies |
(24) |
(30) |
20 |
Litigation and conduct |
- |
- |
|
Total operating expenses |
(258) |
(251) |
(3) |
Other net income |
- |
- |
|
Profit before impairment |
226 |
183 |
23 |
Credit impairment charges |
(19) |
(15) |
(27) |
Profit before tax |
207 |
168 |
23 |
Attributable profit |
142 |
113 |
26 |
|
|
|
|
Performance measures |
|
|
|
Return on average allocated tangible equity |
17.1% |
15.2% |
|
Average allocated tangible equity (£bn) |
3.3 |
3.0 |
|
Cost: income ratio |
53% |
58% |
|
Loan loss rate (bps) |
28 |
23 |
|
|
|
|
|
|
As at 31.03.25 |
As at 31.12.24 |
As at 31.03.24 |
Balance sheet information |
£bn |
£bn |
£bn |
Loans and advances to customers at amortised cost |
26.7 |
25.4 |
25.7 |
Deposits at amortised cost |
85.3 |
83.1 |
81.7 |
Risk weighted assets |
24.2 |
23.9 |
21.4 |
Period end allocated tangible equity |
3.4 |
3.3 |
3.0 |
|
|
|
|
|
Three months ended |
||
|
31.03.25 |
31.03.24 |
|
Analysis of total income |
£m |
£m |
% Change |
Corporate lending |
80 |
72 |
11 |
Transaction banking |
404 |
362 |
12 |
Total income |
484 |
434 |
12 |
UKCB delivered a RoTE of 17.1% (Q124: 15.2%), as increased income from higher average deposits and lending balances was partially offset by continuing investment to support future growth ambitions.
Income statement - Q125 compared to Q124
• Profit before tax increased 23% to £207m
• Total income increased 12% to £484m. Net interest income increased 23% to £342m driven by higher average deposits and lending balances. Net fee, commission, trading and other income decreased 10% to £142m due to the non-repeat of prior year one-off gains
• Total operating expenses increased 3% to £258m, reflecting higher investment spend to support business growth ambitions with ongoing efficiency savings offsetting inflationary headwinds
• Credit impairment charges were £19m (Q124: £15m), driven by stable underlying credit performance and limited single name charges
Balance sheet - 31 March 2025 compared to 31 December 2024
• Loans and advances to customers at amortised cost increased to £26.7bn (December 2024: £25.4bn), reflecting the strategic focus to grow customer lending
• Customer deposits at amortised cost increased to £85.3bn (December 2024: £83.1bn), driven by an inflow of balances from new and existing customers
• RWAs were broadly stable at £24.2bn (December 2024: £23.9bn)
Barclays Private Bank and Wealth Management |
Three months ended |
||
|
31.03.25 |
31.03.24 |
|
Income statement information |
£m |
£m |
% Change |
Net interest income |
204 |
175 |
17 |
Net fee, commission and other income |
145 |
137 |
6 |
Total income |
349 |
312 |
12 |
Operating costs |
(234) |
(214) |
(9) |
UK regulatory levies |
(2) |
(3) |
33 |
Litigation and conduct |
- |
- |
|
Total operating expenses |
(236) |
(217) |
(9) |
Other net income |
- |
- |
|
Profit before impairment |
113 |
95 |
19 |
Credit impairment releases |
9 |
- |
|
Profit before tax |
122 |
95 |
28 |
Attributable profit |
96 |
74 |
30 |
|
|
|
|
Performance measures |
|
|
|
Return on average allocated tangible equity |
34.5% |
28.7% |
|
Average allocated tangible equity (£bn) |
1.1 |
1.0 |
|
Cost: income ratio |
68% |
70% |
|
Loan loss rate (bps) |
(25) |
- |
|
|
|
|
|
|
As at 31.03.25 |
As at 31.12.24 |
As at 31.03.24 |
Key facts |
£bn |
£bn |
£bn |
Net new assets under management1 |
1.0 |
0.7 |
0.2 |
Invested assets2 |
124.4 |
124.6 |
113.2 |
Clients assets and liabilities3 |
212.4 |
208.9 |
189.1 |
|
|
|
|
|
As at 31.03.25 |
As at 31.12.24 |
As at 31.03.24 |
Balance sheet information |
£bn |
£bn |
£bn |
Loans and advances to customers at amortised cost |
14.5 |
14.5 |
13.7 |
Deposits at amortised cost |
73.1 |
69.5 |
61.9 |
Risk weighted assets |
8.0 |
7.9 |
7.2 |
Period end allocated tangible equity |
1.1 |
1.1 |
1.0 |
PBWM delivered a RoTE of 34.5% (Q124: 28.7%), as strong growth in income due to continued inflow of client balances was partially offset by continued investment in people, product and platform.
Income statement - Q125 compared to Q124
• Profit before tax increased 28% to £122m
• Total income increased 12% to £349m driven by growth in deposits and invested asset balances from net new inflows and market movements, along with higher transactional activity due to market volatility
• Total operating expenses increased 9% to £236m, reflecting higher investment spend to support business growth ambitions with ongoing efficiency savings offsetting inflationary headwinds
Balance sheet - 31 March 2025 compared to 31 December 2024
• Client assets and liabilities increased £3.5bn to £212.4bn, driven by net new deposits and assets under management inflows, partially offset by the impact of FX and market movements
• RWAs were stable at £8.0bn (December 2024: £7.9bn)
1 |
Net new assets under management reflects the net inflows and outflows of client balances within Discretionary and Advisory mandates. It excludes market performance and foreign exchange translation, but includes dividend payments. |
2 |
Invested assets represent assets under management and supervision. |
3 |
Client assets and liabilities refers to customer deposits, lending and invested assets |
Barclays Investment Bank |
Three months ended |
||
|
31.03.25 |
31.03.24 |
|
Income statement information |
£m |
£m |
% Change |
Net interest income |
297 |
197 |
51 |
Net trading income |
2,416 |
1,982 |
22 |
Net fee, commission and other income |
1,160 |
1,149 |
1 |
Total income |
3,873 |
3,328 |
16 |
Operating costs |
(2,061) |
(1,957) |
(5) |
UK regulatory levies |
(27) |
(33) |
18 |
Litigation and conduct |
(3) |
(9) |
67 |
Total operating expenses |
(2,091) |
(1,999) |
(5) |
Other net income |
- |
- |
|
Profit before impairment |
1,782 |
1,329 |
34 |
Credit impairment (charges)/releases |
(72) |
10 |
|
Profit before tax |
1,710 |
1,339 |
28 |
Attributable profit |
1,199 |
899 |
33 |
|
|
|
|
Performance measures |
|
|
|
Return on average allocated tangible equity |
16.2% |
12.0% |
|
Average allocated tangible equity (£bn) |
29.6 |
30.0 |
|
Cost: income ratio |
54% |
60% |
|
Loan loss rate (bps) |
23 |
(4) |
|
|
|
|
|
|
As at 31.03.25 |
As at 31.12.24 |
As at 31.03.24 |
Balance sheet information |
£bn |
£bn |
£bn |
Loans and advances to customers at amortised cost |
68.6 |
69.7 |
64.6 |
Loans and advances to banks at amortised cost |
7.4 |
6.8 |
7.6 |
Debt securities at amortised cost |
53.1 |
47.9 |
40.4 |
Loans and advances at amortised cost |
129.1 |
124.4 |
112.6 |
Trading portfolio assets |
185.5 |
166.1 |
195.3 |
Derivative financial instrument assets |
253.6 |
291.6 |
248.9 |
Financial assets at fair value through the income statement |
209.5 |
190.4 |
225.1 |
Cash collateral and settlement balances |
148.8 |
111.1 |
129.8 |
|
|
|
|
Deposits at amortised cost |
148.9 |
140.5 |
151.1 |
Derivative financial instrument liabilities |
245.1 |
279.0 |
241.5 |
|
|
|
|
Risk weighted assets |
195.9 |
198.8 |
200.4 |
Period end allocated tangible equity |
28.9 |
29.3 |
29.6 |
|
Three months ended |
||
|
31.03.25 |
31.03.24 |
|
Analysis of total income |
£m |
£m |
% Change |
FICC |
1,699 |
1,404 |
21 |
Equities |
963 |
883 |
9 |
Global Markets |
2,662 |
2,287 |
16 |
Advisory |
143 |
148 |
(3) |
Equity capital markets |
70 |
68 |
3 |
Debt capital markets |
431 |
401 |
7 |
Banking fees and underwriting |
644 |
617 |
4 |
Corporate lending |
156 |
42 |
|
Transaction banking |
411 |
382 |
8 |
International Corporate Bank |
567 |
424 |
34 |
Investment Banking |
1,211 |
1,041 |
16 |
Total income |
3,873 |
3,328 |
16 |
IB delivered a RoTE of 16.2% (Q124: 12.0%) with Markets and Investment Banking supporting clients in a volatile environment. This was supported by improved RWA productivity and positive operating jaws.
Income statement - Q125 compared to Q124
• Profit before tax increased to £1,710m (Q124: £1,339m)
• Total income increased 16% to £3,873m
- Global Markets income increased 16% to £2,662m driven by increased income across FICC and Equities
- FICC income increased 21% to £1,699m, reflecting increased volatility and client activity, including a strong performance in Macro and Securitised Products, and continued strength in Financing
- Equities income increased 9% to £963m, (27% excluding the prior year £125m fair value gain on Visa B shares), reflecting elevated volatility and client activity in Derivatives and growth in Prime
- Investment Banking income increased 16% to £1,211m
- Banking fees and underwriting income increased 4% to £644m reflecting increased market share1
- International Corporate Bank income increased 34% to £567m. Corporate lending income increased to £156m due to fair value gains on leverage finance lending (c.£105m). Transaction banking income increased 8% to £411m, as higher income from growth in deposit balances was partially offset by margin compression due to change in deposits product mix
• Total operating expenses increased 5% to £2,091m driven by the impact of inflation, partially offset by efficiency savings
• Credit impairment charges were £72m (Q124: £10m release), primarily driven by a post model adjustment of net £36m for elevated US macroeconomic uncertainty, and single name charges including the benefit of credit protection
Balance sheet - 31 March 2025 compared to 31 December 2024
• Loans and advances at amortised costs increased £4.7bn to £129.1bn (December £124.4bn), driven by stable lending and increased investment in debt securities in treasury
• Trading portfolio assets increased £19.4bn to £185.5bn (December £166.1bn), driven by increased trading in debt securities to facilitate client demand in Global Markets
• Derivative assets decreased £38.0bn to £253.6bn and liabilities decreased £33.9bn to £245.1bn, primarily driven by decreased mark-to-market value on FX derivatives as a result of USD depreciation in Q125
• Deposits at amortised cost increased £8.4bn to £148.9bn, driven by growth in deposits across the business
• RWAs decreased to £195.9bn (December 2024: £198.8bn) mainly driven by FX as GBP strengthened against USD, with lower credit risk offset by higher market risk as we continued to support clients through a period of volatility
1 |
Data source: Dealogic for the period covering 1 January to 31 March 2025. |
Barclays US Consumer Bank |
Three months ended |
||
|
31.03.25 |
31.03.24 |
|
Income statement information |
£m |
£m |
% Change |
Net interest income |
678 |
688 |
(1) |
Net fee, commission and other income |
186 |
171 |
9 |
Total income |
864 |
859 |
1 |
Operating costs |
(407) |
(387) |
(5) |
UK regulatory levies |
- |
- |
|
Litigation and conduct |
(3) |
(3) |
|
Total operating expenses |
(410) |
(390) |
(5) |
Other net income |
- |
- |
|
Profit before impairment |
454 |
469 |
(3) |
Credit impairment charges |
(399) |
(410) |
3 |
Profit before tax |
55 |
59 |
(7) |
Attributable profit |
41 |
44 |
(7) |
|
|
|
|
Performance measures |
|
|
|
Return on average allocated tangible equity |
4.5% |
5.3% |
|
Average allocated tangible equity (£bn) |
3.6 |
3.3 |
|
Cost: income ratio |
47% |
46% |
|
Loan loss rate (bps) |
562 |
610 |
|
Net interest margin |
10.53% |
11.12% |
|
|
|
|
|
|
As at 31.03.25 |
As at 31.12.24 |
As at 31.03.24 |
Balance sheet information |
£bn |
£bn |
£bn |
Loans and advances to customers at amortised cost |
18.8 |
20.0 |
23.6 |
Deposits at amortised cost |
23.8 |
23.3 |
20.3 |
Risk weighted assets |
25.6 |
26.8 |
23.9 |
Period end allocated tangible equity |
3.5 |
3.7 |
3.3 |
USCB delivered a RoTE of 4.5% (Q124: 5.3%), as income improvement and broadly stable delinquencies were offset by higher costs and the inclusion of a post model adjustment for elevated US macroeconomic uncertainty.
Income statement - Q125 compared to Q124
• Profit before tax was £55m (Q124: £59m)
• Total income increased 1% to £864m, as underlying business growth was offset by the non-repeat of a gain on sale and foregone interest income from $1.1bn receivables sold to Blackstone in Q124. NII reduced 1% to £678m reflecting margin compression from the lower interest rate environment. Net fee, commission and other income increased 9% to £186m driven by account and purchase growth as well as benefits from interest rate hedges which offset the margin compression in NII
• Total operating expenses increased 5% to £410m, driven by business growth and inflation, partially offset by efficiency savings
• Credit impairment charges were £399m (Q124: £410m), including a post model adjustment of £38m for elevated US macroeconomic uncertainty, with broadly stable delinquencies in US cards. US cards 30 and 90 day arrears were 3.0%1 (Q124: 3.1%) and 1.6%1 (Q124: 1.7%) respectively. The USCB total coverage ratio was 12.0% (December 2024: 11.4%)
Balance sheet - 31 March 2025 compared to 31 December 2024
• Loans and advances to customers at amortised cost reduced to £18.8bn (December 2024: £20.0bn), reflecting a decrease in receivables due to seasonality and the strengthening of GBP against USD
• Customer deposits at amortised cost increased to £23.8bn (December 2024: £23.3bn), with growth in underlying retail savings which is in line with USCB's ambition to grow core deposits, partially offset by the strengthening of GBP against USD
• RWAs decreased to £25.6bn (December 2024: £26.8bn), driven by decreased balances due to seasonality and the strengthening of GBP against USD
1 |
Including a co-branded cards portfolio classified as assets held for sale. |
Head Office |
Three months ended |
||
|
31.03.25 |
31.03.24 |
|
Income statement information |
£m |
£m |
% Change |
Net interest income |
174 |
186 |
(6) |
Net fee, commission and other income |
(109) |
8 |
|
Total income |
65 |
194 |
(66) |
Operating costs |
(207) |
(211) |
2 |
UK regulatory levies |
- |
- |
|
Litigation and conduct |
(3) |
(44) |
93 |
Total operating expenses |
(210) |
(255) |
18 |
Other net income |
18 |
12 |
50 |
Loss before impairment |
(127) |
(49) |
|
Credit impairment charges |
(4) |
(40) |
90 |
Loss before tax |
(131) |
(89) |
(47) |
Attributable loss |
(124) |
(59) |
|
|
|
|
|
Performance measures |
|
|
|
Average allocated tangible equity (£bn) |
3.8 |
2.8 |
|
|
|
|
|
|
As at 31.03.25 |
As at 31.12.24 |
As at 31.03.24 |
Balance sheet information |
£bn |
£bn |
£bn |
Risk weighted assets |
12.7 |
16.2 |
20.2 |
Period end allocated tangible equity |
4.7 |
2.4 |
3.0 |
Income statement - Q125 compared to Q124
• Loss before tax was £131m (Q124: £89m)
• Total income decreased to £65m (Q124: £194m), primarily from the non-recurrence of the prior year gain on disposal of a legacy investment and the impact of the disposal of the German consumer finance business in early Q125
• Total operating expenses decreased to £210m (Q124: £255m), primarily from lower litigation and conduct charges and the impact of the disposal of the German consumer finance business in early Q125, partially offset by the c.£50m expense for the employee share grant announced at FY24 Results
• Credit impairment charges decreased to £4m (Q124: £40m), driven by the disposal of the German consumer finance business in early Q125 and the disposal of the Italian mortgage portfolios in FY24
Balance sheet - 31 March 2025 compared to 31 December 2024
• RWAs decreased to £12.7bn (December 2024: £16.2bn), primarily driven by the disposal of the German consumer finance business
Quarterly Results Summary
Barclays Group |
|
|
|
|
|
|
|
|
|
|
|
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
3,517 |
|
3,500 |
3,308 |
3,056 |
3,072 |
|
3,139 |
3,247 |
3,270 |
Net fee, commission and other income |
4,192 |
|
3,464 |
3,239 |
3,268 |
3,881 |
|
2,459 |
3,011 |
3,015 |
Total income |
7,709 |
|
6,964 |
6,547 |
6,324 |
6,953 |
|
5,598 |
6,258 |
6,285 |
Operating costs |
(4,258) |
|
(4,244) |
(3,954) |
(3,999) |
(3,998) |
|
(4,735) |
(3,949) |
(3,919) |
UK regulatory levies |
(96) |
|
(227) |
27 |
- |
(120) |
|
(180) |
- |
- |
Litigation and conduct |
(11) |
|
(121) |
(35) |
(7) |
(57) |
|
(5) |
- |
(33) |
Total operating expenses |
(4,365) |
|
(4,592) |
(3,962) |
(4,006) |
(4,175) |
|
(4,920) |
(3,949) |
(3,952) |
Other net income/(expenses) |
18 |
|
- |
21 |
4 |
12 |
|
(16) |
9 |
3 |
Profit before impairment |
3,362 |
|
2,372 |
2,606 |
2,322 |
2,790 |
|
662 |
2,318 |
2,336 |
Credit impairment charges |
(643) |
|
(711) |
(374) |
(384) |
(513) |
|
(552) |
(433) |
(372) |
Profit before tax |
2,719 |
|
1,661 |
2,232 |
1,938 |
2,277 |
|
110 |
1,885 |
1,964 |
Tax (charges)/credit |
(621) |
|
(448) |
(412) |
(427) |
(465) |
|
23 |
(343) |
(353) |
Profit after tax |
2,098 |
|
1,213 |
1,820 |
1,511 |
1,812 |
|
133 |
1,542 |
1,611 |
Non-controlling interests |
(2) |
|
(20) |
(3) |
(23) |
(3) |
|
(25) |
(9) |
(22) |
Other equity instrument holders |
(232) |
|
(228) |
(253) |
(251) |
(259) |
|
(219) |
(259) |
(261) |
Attributable profit/(loss) |
1,864 |
|
965 |
1,564 |
1,237 |
1,550 |
|
(111) |
1,274 |
1,328 |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity |
14.0% |
|
7.5% |
12.3% |
9.9% |
12.3% |
|
(0.9)% |
11.0% |
11.4% |
Average tangible shareholders' equity (£bn) |
53.1 |
|
51.5 |
51.0 |
49.8 |
50.5 |
|
48.9 |
46.5 |
46.7 |
Cost: income ratio |
57% |
|
66% |
61% |
63% |
60% |
|
88% |
63% |
63% |
Loan loss rate (bps) |
61 |
|
66 |
37 |
38 |
51 |
|
54 |
42 |
37 |
Basic earnings per ordinary share |
13.0p |
|
6.7p |
10.7p |
8.3p |
10.3p |
|
(0.7)p |
8.3p |
8.6p |
Basic weighted average number of shares (m) |
14,314 |
|
14,432 |
14,648 |
14,915 |
14,983 |
|
15,092 |
15,405 |
15,523 |
Period end number of shares (m) |
14,336 |
|
14,420 |
14,571 |
14,826 |
15,091 |
|
15,155 |
15,239 |
15,556 |
Period end tangible shareholders' equity (£bn) |
53.4 |
|
51.5 |
51.1 |
50.4 |
50.6 |
|
50.2 |
48.2 |
45.3 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet and capital management1 |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Loans and advances to customers at amortised cost |
338.6 |
|
337.9 |
326.5 |
329.8 |
332.1 |
|
333.3 |
339.6 |
337.4 |
Loans and advances to banks at amortised cost |
9.4 |
|
8.3 |
8.1 |
8.0 |
8.5 |
|
9.5 |
11.5 |
10.9 |
Debt securities at amortised cost |
71.4 |
|
68.2 |
64.6 |
61.7 |
57.4 |
|
56.7 |
54.3 |
53.1 |
Loans and advances at amortised cost |
419.4 |
|
414.5 |
399.2 |
399.5 |
397.9 |
|
399.5 |
405.4 |
401.4 |
Loans and advances at amortised cost impairment coverage ratio |
1.2% |
|
1.2% |
1.3% |
1.4% |
1.4% |
|
1.4% |
1.4% |
1.4% |
Total assets |
1,593.5 |
|
1,518.2 |
1,531.1 |
1,576.6 |
1,577.1 |
|
1,477.5 |
1,591.7 |
1,549.7 |
Deposits at amortised cost |
574.3 |
|
560.7 |
542.8 |
557.5 |
552.3 |
|
538.8 |
561.3 |
554.7 |
Tangible net asset value per share |
372p |
|
357p |
351p |
340p |
335p |
|
331p |
316p |
291p |
Common equity tier 1 ratio |
13.9% |
|
13.6% |
13.8% |
13.6% |
13.5% |
|
13.8% |
14.0% |
13.8% |
Common equity tier 1 capital |
48.8 |
|
48.6 |
47.0 |
47.7 |
47.1 |
|
47.3 |
48.0 |
46.6 |
Risk weighted assets |
351.3 |
|
358.1 |
340.4 |
351.4 |
349.6 |
|
342.7 |
341.9 |
336.9 |
UK leverage ratio |
5.0% |
|
5.0% |
4.9% |
5.0% |
4.9% |
|
5.2% |
5.0% |
5.1% |
UK leverage exposure |
1,252.8 |
|
1,206.5 |
1,197.4 |
1,222.7 |
1,226.5 |
|
1,168.3 |
1,202.4 |
1,183.7 |
|
|
|
|
|
|
|
|
|
|
|
Funding and liquidity |
|
|
|
|
|
|
|
|
|
|
Group liquidity pool (£bn) |
336.3 |
|
296.9 |
311.7 |
328.7 |
323.5 |
|
298.1 |
335.0 |
330.7 |
Liquidity coverage ratio |
175.3% |
|
172.4% |
170.1% |
167.0% |
163.2% |
|
161.4% |
158.7% |
157.2% |
Net stable funding ratio |
136.2% |
|
134.9% |
135.6% |
136.4% |
135.7% |
|
138.0% |
138.2% |
138.8% |
Loan: deposit ratio |
73% |
|
74% |
74% |
72% |
72% |
|
74% |
72% |
72% |
1 |
Refer to pages 33 to 37 for further information on how capital, RWAs and leverage are calculated. |
Barclays UK |
|
|
|
|
|
|
|
|
|
|
|
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
1,822 |
|
1,815 |
1,666 |
1,597 |
1,549 |
|
1,575 |
1,578 |
1,660 |
Net fee, commission and other income |
252 |
|
800 |
280 |
290 |
277 |
|
217 |
295 |
301 |
Total income |
2,074 |
|
2,615 |
1,946 |
1,887 |
1,826 |
|
1,792 |
1,873 |
1,961 |
Operating costs |
(1,115) |
|
(1,170) |
(1,017) |
(1,041) |
(1,007) |
|
(1,153) |
(1,058) |
(1,090) |
UK regulatory levies |
(43) |
|
(36) |
12 |
- |
(54) |
|
(30) |
- |
- |
Litigation and conduct |
(2) |
|
(9) |
(1) |
(4) |
(2) |
|
(4) |
9 |
5 |
Total operating expenses |
(1,160) |
|
(1,215) |
(1,006) |
(1,045) |
(1,063) |
|
(1,187) |
(1,049) |
(1,085) |
Other net income |
- |
|
- |
- |
- |
- |
|
- |
- |
- |
Profit before impairment |
914 |
|
1,400 |
940 |
842 |
763 |
|
605 |
824 |
876 |
Credit impairment charges |
(158) |
|
(283) |
(16) |
(8) |
(58) |
|
(37) |
(59) |
(95) |
Profit before tax |
756 |
|
1,117 |
924 |
834 |
705 |
|
568 |
765 |
781 |
Attributable profit |
510 |
|
781 |
621 |
584 |
479 |
|
382 |
531 |
534 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Loans and advances to customers at amortised cost |
209.6 |
|
207.7 |
199.3 |
198.7 |
200.8 |
|
202.8 |
204.9 |
206.8 |
Customer deposits at amortised cost |
243.1 |
|
244.2 |
236.3 |
236.8 |
237.2 |
|
241.1 |
243.2 |
249.8 |
Loan: deposit ratio |
93% |
|
92% |
92% |
91% |
92% |
|
92% |
92% |
90% |
Risk weighted assets |
85.0 |
|
84.5 |
77.5 |
76.5 |
76.5 |
|
73.5 |
73.2 |
73.0 |
Period end allocated tangible equity |
11.8 |
|
11.6 |
10.7 |
10.6 |
10.7 |
|
10.2 |
10.1 |
10.1 |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
17.4% |
|
28.0% |
23.4% |
22.3% |
18.5% |
|
14.9% |
21.0% |
20.9% |
Average allocated tangible equity (£bn) |
11.7 |
|
11.2 |
10.6 |
10.5 |
10.4 |
|
10.2 |
10.1 |
10.2 |
Cost: income ratio |
56% |
|
46% |
52% |
55% |
58% |
|
66% |
56% |
55% |
Loan loss rate (bps) |
28 |
|
49 |
3 |
1 |
11 |
|
7 |
10 |
17 |
Net interest margin |
3.55% |
|
3.53% |
3.34% |
3.22% |
3.09% |
|
3.07% |
3.04% |
3.22% |
Analysis of Barclays UK |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
Analysis of total income |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Personal Banking1 |
1,348 |
|
1,847 |
1,184 |
1,174 |
1,128 |
|
1,067 |
1,165 |
1,244 |
Barclaycard Consumer UK |
225 |
|
231 |
249 |
228 |
229 |
|
242 |
238 |
237 |
Business Banking |
501 |
|
537 |
513 |
485 |
469 |
|
483 |
470 |
480 |
Total income |
2,074 |
|
2,615 |
1,946 |
1,887 |
1,826 |
|
1,792 |
1,873 |
1,961 |
|
|
|
|
|
|
|
|
|
|
|
Analysis of credit impairment (charges)/releases |
|
|
|
|
|
|
|
|
|
|
Personal Banking1 |
(107) |
|
(244) |
3 |
(26) |
(14) |
|
35 |
(85) |
(92) |
Barclaycard Consumer UK |
(38) |
|
(35) |
(15) |
(25) |
(38) |
|
(73) |
29 |
(35) |
Business Banking |
(13) |
|
(4) |
(4) |
43 |
(6) |
|
1 |
(3) |
32 |
Total credit impairment charges |
(158) |
|
(283) |
(16) |
(8) |
(58) |
|
(37) |
(59) |
(95) |
|
|
|
|
|
|
|
|
|
|
|
Analysis of loans and advances to customers at amortised cost |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Personal Banking1 |
179.3 |
|
177.0 |
168.1 |
167.3 |
169.0 |
|
170.1 |
172.3 |
173.3 |
Barclaycard Consumer UK |
11.1 |
|
11.0 |
10.6 |
10.2 |
9.8 |
|
9.7 |
9.6 |
9.3 |
Business Banking |
19.2 |
|
19.7 |
20.6 |
21.2 |
22.0 |
|
23.0 |
23.0 |
24.2 |
Total loans and advances to customers at amortised cost |
209.6 |
|
207.7 |
199.3 |
198.7 |
200.8 |
|
202.8 |
204.9 |
206.8 |
|
|
|
|
|
|
|
|
|
|
|
Analysis of customer deposits at amortised cost |
|
|
|
|
|
|
|
|
|
|
Personal Banking1 |
190.8 |
|
191.4 |
182.9 |
183.3 |
183.4 |
|
185.4 |
186.1 |
191.1 |
Barclaycard Consumer UK |
- |
|
- |
- |
- |
- |
|
- |
- |
- |
Business Banking |
52.3 |
|
52.8 |
53.4 |
53.5 |
53.8 |
|
55.7 |
57.1 |
58.7 |
Total customer deposits at amortised cost |
243.1 |
|
244.2 |
236.3 |
236.8 |
237.2 |
|
241.1 |
243.2 |
249.8 |
1 |
Following the completion of the acquisition on 1 November 2024, Tesco Bank is reported in Personal Banking. |
Barclays UK Corporate Bank |
|
|
|
|
|
|
|
|
|
|
|
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
342 |
|
324 |
309 |
296 |
277 |
|
247 |
304 |
299 |
Net fee, commission, trading and other income |
142 |
|
134 |
136 |
147 |
157 |
|
148 |
136 |
173 |
Total income |
484 |
|
458 |
445 |
443 |
434 |
|
395 |
440 |
472 |
Operating costs |
(234) |
|
(250) |
(229) |
(235) |
(221) |
|
(258) |
(224) |
(213) |
UK regulatory levies |
(24) |
|
(14) |
7 |
- |
(30) |
|
(8) |
- |
- |
Litigation and conduct |
- |
|
(1) |
- |
- |
- |
|
(1) |
2 |
- |
Total operating expenses |
(258) |
|
(265) |
(222) |
(235) |
(251) |
|
(267) |
(222) |
(213) |
Other net (expenses)/income |
- |
|
- |
- |
- |
- |
|
(5) |
- |
1 |
Profit before impairment |
226 |
|
193 |
223 |
208 |
183 |
|
123 |
218 |
260 |
Credit impairment (charges)/releases |
(19) |
|
(40) |
(13) |
(8) |
(15) |
|
(18) |
(15) |
84 |
Profit before tax |
207 |
|
153 |
210 |
200 |
168 |
|
105 |
203 |
344 |
Attributable profit |
142 |
|
98 |
144 |
135 |
113 |
|
59 |
129 |
239 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Loans and advances to customers at amortised cost |
26.7 |
|
25.4 |
24.8 |
25.7 |
25.7 |
|
26.4 |
26.9 |
26.9 |
Deposits at amortised cost |
85.3 |
|
83.1 |
82.3 |
84.9 |
81.7 |
|
84.9 |
82.7 |
82.6 |
Risk weighted assets |
24.2 |
|
23.9 |
22.1 |
21.9 |
21.4 |
|
20.9 |
19.5 |
20.6 |
Period end allocated tangible equity |
3.4 |
|
3.3 |
3.0 |
3.0 |
3.0 |
|
3.0 |
2.8 |
2.9 |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
17.1% |
|
12.3% |
18.8% |
18.0% |
15.2% |
|
8.4% |
18.3% |
32.9% |
Average allocated tangible equity (£bn) |
3.3 |
|
3.2 |
3.1 |
3.0 |
3.0 |
|
2.8 |
2.8 |
2.9 |
Cost: income ratio |
53% |
|
58% |
50% |
53% |
58% |
|
68% |
50% |
45% |
Loan loss rate (bps) |
28 |
|
62 |
21 |
12 |
23 |
|
27 |
21 |
(123) |
|
|
|
|
|
|
|
|
|
|
|
Analysis of total income |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Corporate lending |
80 |
|
71 |
67 |
57 |
72 |
|
64 |
69 |
68 |
Transaction banking |
404 |
|
387 |
378 |
386 |
362 |
|
331 |
371 |
404 |
Total income |
484 |
|
458 |
445 |
443 |
434 |
|
395 |
440 |
472 |
Barclays Private Bank and Wealth Management |
|
|
|
|
|
|
|
|
|
|
|
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
204 |
|
216 |
189 |
187 |
175 |
|
182 |
219 |
186 |
Net fee, commission and other income |
145 |
|
135 |
137 |
133 |
137 |
|
131 |
118 |
113 |
Total income |
349 |
|
351 |
326 |
320 |
312 |
|
313 |
337 |
299 |
Operating costs |
(234) |
|
(255) |
(222) |
(220) |
(214) |
|
(255) |
(214) |
(182) |
UK regulatory levies |
(2) |
|
(7) |
1 |
- |
(3) |
|
(4) |
- |
- |
Litigation and conduct |
- |
|
(1) |
- |
1 |
- |
|
2 |
- |
- |
Total operating expenses |
(236) |
|
(263) |
(221) |
(219) |
(217) |
|
(257) |
(214) |
(182) |
Other net income |
- |
|
- |
- |
- |
- |
|
- |
- |
- |
Profit before impairment |
113 |
|
88 |
105 |
101 |
95 |
|
56 |
123 |
117 |
Credit impairment releases/(charges) |
9 |
|
(2) |
(7) |
3 |
- |
|
4 |
2 |
(7) |
Profit before tax |
122 |
|
86 |
98 |
104 |
95 |
|
60 |
125 |
110 |
Attributable profit |
96 |
|
63 |
74 |
77 |
74 |
|
47 |
102 |
91 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Loans and advances to customers at amortised cost |
14.5 |
|
14.5 |
14.0 |
13.9 |
13.7 |
|
13.6 |
13.4 |
13.8 |
Deposits at amortised cost |
73.1 |
|
69.5 |
64.8 |
64.6 |
61.9 |
|
60.3 |
59.7 |
59.2 |
Risk weighted assets |
8.0 |
|
7.9 |
7.3 |
7.0 |
7.2 |
|
7.2 |
7.2 |
7.2 |
Period end allocated tangible equity |
1.1 |
|
1.1 |
1.0 |
1.0 |
1.0 |
|
1.0 |
1.0 |
1.0 |
Client assets and liabilities1 |
212.4 |
|
208.9 |
201.5 |
198.5 |
189.1 |
|
182.9 |
178.7 |
174.1 |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
34.5% |
|
23.9% |
29.0% |
30.8% |
28.7% |
|
19.1% |
41.2% |
35.9% |
Average allocated tangible equity (£bn) |
1.1 |
|
1.1 |
1.0 |
1.0 |
1.0 |
|
1.0 |
1.0 |
1.0 |
Cost: income ratio |
68% |
|
75% |
68% |
68% |
70% |
|
82% |
63% |
61% |
Loan loss rate (bps) |
(25) |
|
5 |
19 |
(9) |
- |
|
(10) |
(7) |
20 |
1 |
Client assets and liabilities refers to customer deposits, lending and invested assets. |
Barclays Investment Bank |
|
|
|
|
|
|
|
|
|
|
|
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
297 |
|
284 |
282 |
268 |
197 |
|
282 |
397 |
555 |
Net trading income |
2,416 |
|
1,262 |
1,512 |
1,485 |
1,982 |
|
757 |
1,497 |
1,351 |
Net fee, commission and other income |
1,160 |
|
1,061 |
1,057 |
1,266 |
1,149 |
|
998 |
792 |
837 |
Total income |
3,873 |
|
2,607 |
2,851 |
3,019 |
3,328 |
|
2,037 |
2,686 |
2,743 |
Operating costs |
(2,061) |
|
(1,903) |
(1,906) |
(1,900) |
(1,957) |
|
(1,934) |
(1,840) |
(1,813) |
UK regulatory levies |
(27) |
|
(161) |
7 |
- |
(33) |
|
(123) |
- |
- |
Litigation and conduct |
(3) |
|
(26) |
(17) |
(3) |
(9) |
|
(2) |
6 |
(1) |
Total operating expenses |
(2,091) |
|
(2,090) |
(1,916) |
(1,903) |
(1,999) |
|
(2,059) |
(1,834) |
(1,814) |
Other net (expenses)/income |
- |
|
- |
- |
- |
- |
|
(1) |
2 |
- |
Profit/(loss) before impairment |
1,782 |
|
517 |
935 |
1,116 |
1,329 |
|
(23) |
854 |
929 |
Credit impairment (charges)/releases |
(72) |
|
(46) |
(43) |
(44) |
10 |
|
(23) |
23 |
(77) |
Profit/(loss) before tax |
1,710 |
|
471 |
892 |
1,072 |
1,339 |
|
(46) |
877 |
852 |
Attributable profit/(loss) |
1,199 |
|
247 |
652 |
715 |
899 |
|
(149) |
580 |
562 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Loans and advances to customers at amortised cost |
68.6 |
|
69.7 |
64.5 |
66.6 |
64.6 |
|
62.7 |
62.3 |
59.1 |
Loans and advances to banks at amortised cost |
7.4 |
|
6.8 |
6.7 |
6.6 |
7.6 |
|
7.3 |
9.5 |
9.0 |
Debt securities at amortised cost |
53.1 |
|
47.9 |
44.8 |
41.7 |
40.4 |
|
38.9 |
36.3 |
35.1 |
Loans and advances at amortised cost |
129.1 |
|
124.4 |
116.0 |
114.9 |
112.6 |
|
108.9 |
108.1 |
103.2 |
Trading portfolio assets |
185.5 |
|
166.1 |
185.8 |
197.2 |
195.3 |
|
174.5 |
155.3 |
165.0 |
Derivative financial instrument assets |
253.6 |
|
291.6 |
256.7 |
251.4 |
248.9 |
|
255.1 |
280.4 |
264.8 |
Financial assets at fair value through the income statement |
209.5 |
|
190.4 |
210.8 |
211.7 |
225.1 |
|
202.5 |
237.2 |
231.1 |
Cash collateral and settlement balances |
148.8 |
|
111.1 |
134.7 |
139.8 |
129.8 |
|
102.3 |
134.6 |
122.1 |
|
|
|
|
|
|
|
|
|
|
|
Deposits at amortised cost |
148.9 |
|
140.5 |
139.8 |
151.3 |
151.1 |
|
132.7 |
154.2 |
142.9 |
Derivative financial instrument liabilities |
245.1 |
|
279.0 |
249.4 |
241.8 |
241.5 |
|
249.7 |
268.3 |
254.5 |
|
|
|
|
|
|
|
|
|
|
|
Risk weighted assets |
195.9 |
|
198.8 |
194.2 |
203.3 |
200.4 |
|
197.3 |
201.1 |
197.2 |
Period end allocated tangible equity |
28.9 |
|
29.3 |
28.4 |
29.7 |
29.6 |
|
29.0 |
29.0 |
28.7 |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
16.2% |
|
3.4% |
8.8% |
9.6% |
12.0% |
|
(2.1)% |
8.0% |
7.7% |
Average allocated tangible equity (£bn) |
29.6 |
|
29.3 |
29.5 |
29.9 |
30.0 |
|
28.9 |
28.8 |
29.0 |
Cost: income ratio |
54% |
|
80% |
67% |
63% |
60% |
|
101% |
68% |
66% |
Loan loss rate (bps) |
23 |
|
15 |
15 |
15 |
(4) |
|
8 |
(8) |
30 |
|
|
|
|
|
|
|
|
|
|
|
Analysis of total income |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
FICC |
1,699 |
|
934 |
1,180 |
1,149 |
1,404 |
|
724 |
1,147 |
1,186 |
Equities |
963 |
|
604 |
692 |
696 |
883 |
|
431 |
675 |
563 |
Global Markets |
2,662 |
|
1,538 |
1,872 |
1,845 |
2,287 |
|
1,155 |
1,822 |
1,749 |
Advisory |
143 |
|
189 |
186 |
138 |
148 |
|
171 |
80 |
130 |
Equity capital markets |
70 |
|
98 |
64 |
121 |
68 |
|
38 |
62 |
69 |
Debt capital markets |
431 |
|
327 |
344 |
420 |
401 |
|
301 |
233 |
273 |
Banking Fees and Underwriting |
644 |
|
614 |
594 |
679 |
617 |
|
510 |
375 |
472 |
Corporate lending |
156 |
|
45 |
(21) |
87 |
42 |
|
(23) |
103 |
100 |
Transaction banking |
411 |
|
410 |
406 |
408 |
382 |
|
395 |
386 |
422 |
International Corporate Banking |
567 |
|
455 |
385 |
495 |
424 |
|
372 |
489 |
522 |
Investment Banking |
1,211 |
|
1,069 |
979 |
1,174 |
1,041 |
|
882 |
864 |
994 |
Total income |
3,873 |
|
2,607 |
2,851 |
3,019 |
3,328 |
|
2,037 |
2,686 |
2,743 |
Barclays US Consumer Bank |
|
|
|
|
|
|
|
|
|
|
|
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
678 |
|
678 |
647 |
646 |
688 |
|
686 |
662 |
622 |
Net fee, commission, trading and other income |
186 |
|
179 |
144 |
173 |
171 |
|
180 |
147 |
145 |
Total income |
864 |
|
857 |
791 |
819 |
859 |
|
866 |
809 |
767 |
Operating costs |
(407) |
|
(433) |
(384) |
(408) |
(387) |
|
(418) |
(404) |
(401) |
UK regulatory levies |
- |
|
- |
- |
- |
- |
|
- |
- |
- |
Litigation and conduct |
(3) |
|
- |
(9) |
(2) |
(3) |
|
(2) |
- |
(4) |
Total operating expenses |
(410) |
|
(433) |
(393) |
(410) |
(390) |
|
(420) |
(404) |
(405) |
Other net income |
- |
|
- |
- |
- |
- |
|
- |
- |
- |
Profit before impairment |
454 |
|
424 |
398 |
409 |
469 |
|
446 |
405 |
362 |
Credit impairment charges |
(399) |
|
(298) |
(276) |
(309) |
(410) |
|
(449) |
(404) |
(264) |
Profit/(loss) before tax |
55 |
|
126 |
122 |
100 |
59 |
|
(3) |
1 |
98 |
Attributable profit/(loss) |
41 |
|
94 |
89 |
75 |
44 |
|
(3) |
3 |
72 |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Loans and advances to customers at amortised cost |
18.8 |
|
20.0 |
23.2 |
24.3 |
23.6 |
|
24.2 |
24.3 |
22.9 |
Deposits at amortised cost |
23.8 |
|
23.3 |
19.4 |
20.0 |
20.3 |
|
19.7 |
19.3 |
17.9 |
Risk weighted assets |
25.6 |
|
26.8 |
23.2 |
24.4 |
23.9 |
|
24.8 |
24.1 |
22.5 |
Period end allocated tangible equity |
3.5 |
|
3.7 |
3.2 |
3.3 |
3.3 |
|
3.4 |
3.3 |
3.1 |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
4.5% |
|
11.2% |
10.9% |
9.2% |
5.3% |
|
(0.3)% |
0.4% |
9.3% |
Average allocated tangible equity (£bn) |
3.6 |
|
3.4 |
3.3 |
3.3 |
3.3 |
|
3.3 |
3.1 |
3.1 |
Cost: income ratio |
47% |
|
51% |
50% |
50% |
46% |
|
48% |
50% |
53% |
Loan loss rate (bps)1 |
562 |
|
395 |
411 |
438 |
610 |
|
636 |
582 |
411 |
Net interest margin |
10.53% |
|
10.66% |
10.38% |
10.43% |
11.12% |
|
10.88% |
10.88% |
10.66% |
1 |
LLR includes held for sale portfolios to remain consistent with the treatment of impairment. |
Head Office |
|
|
|
|
|
|
|
|
|
|
|
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
Income statement information |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
Net interest income |
174 |
|
183 |
215 |
62 |
186 |
|
167 |
87 |
(52) |
Net fee, commission and other income |
(109) |
|
(107) |
(27) |
(226) |
8 |
|
28 |
26 |
95 |
Total income |
65 |
|
76 |
188 |
(164) |
194 |
|
195 |
113 |
43 |
Operating costs |
(207) |
|
(233) |
(197) |
(195) |
(211) |
|
(717) |
(210) |
(221) |
UK regulatory levies |
- |
|
(9) |
- |
- |
- |
|
(14) |
- |
- |
Litigation and conduct |
(3) |
|
(84) |
(7) |
1 |
(44) |
|
1 |
(16) |
(32) |
Total operating expenses |
(210) |
|
(326) |
(204) |
(194) |
(255) |
|
(730) |
(226) |
(253) |
Other net income/(expenses) |
18 |
|
- |
21 |
4 |
12 |
|
(10) |
7 |
2 |
(Loss)/profit before impairment |
(127) |
|
(250) |
5 |
(354) |
(49) |
|
(545) |
(106) |
(208) |
Credit impairment (charges)/releases |
(4) |
|
(42) |
(19) |
(18) |
(40) |
|
(29) |
20 |
(13) |
Loss before tax |
(131) |
|
(292) |
(14) |
(372) |
(89) |
|
(574) |
(86) |
(221) |
Attributable loss |
(124) |
|
(318) |
(16) |
(349) |
(59) |
|
(447) |
(71) |
(170) |
|
|
|
|
|
|
|
|
|
|
|
Balance sheet information |
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Risk weighted assets |
12.7 |
|
16.2 |
16.1 |
18.3 |
20.2 |
|
19.0 |
16.8 |
16.4 |
Period end allocated tangible equity |
4.7 |
|
2.4 |
4.9 |
2.7 |
3.0 |
|
3.6 |
2.0 |
(0.5) |
|
|
|
|
|
|
|
|
|
|
|
Performance measures |
|
|
|
|
|
|
|
|
|
|
Average allocated tangible equity (£bn) |
3.8 |
|
3.4 |
3.5 |
2.1 |
2.8 |
|
2.7 |
0.7 |
0.5 |
Performance Management
Margins and balances |
|
|
|
|
|
|
|
Three months ended 31.03.25 |
Three months ended 31.03.24 |
||||
|
Net interest income |
Average customer assets |
Net interest margin |
Net interest income |
Average customer assets |
Net interest margin |
|
£m |
£m |
% |
£m |
£m |
% |
Barclays UK |
1,822 |
208,305 |
3.55 |
1,549 |
201,669 |
3.09 |
Barclays UK Corporate Bank |
342 |
24,605 |
5.64 |
277 |
22,257 |
5.00 |
Barclays Private Bank and Wealth Management |
204 |
14,674 |
5.64 |
175 |
13,593 |
5.17 |
Barclays US Consumer Bank1 |
678 |
26,106 |
10.53 |
688 |
24,880 |
11.12 |
Group excluding IB and Head Office1 |
3,046 |
273,690 |
4.51 |
2,689 |
262,399 |
4.12 |
Barclays Investment Bank |
297 |
|
|
197 |
|
|
Head Office |
174 |
|
|
186 |
|
|
Barclays Group Net interest income |
3,517 |
|
|
3,072 |
|
|
1 |
Average customer assets includes held for sale balances generating net interest income. |
The Group excluding IB and Head Office Net interest margin (NIM) increased by 39bps from 4.12% in Q124 to 4.51% in Q125, due to continued structural hedge momentum, and the impact from the acquisition of Tesco Bank, partially offset by higher average customer assets.
Quarterly analysis |
|
|
|||
|
Q125 |
Q424 |
Q324 |
Q224 |
Q124 |
Net interest income |
£m |
£m |
£m |
£m |
£m |
Barclays UK |
1,822 |
1,815 |
1,666 |
1,597 |
1,549 |
Barclays UK Corporate Bank |
342 |
324 |
309 |
296 |
277 |
Barclays Private Bank and Wealth Management |
204 |
216 |
189 |
187 |
175 |
Barclays US Consumer Bank |
678 |
678 |
647 |
646 |
688 |
Group excluding IB and Head Office |
3,046 |
3,033 |
2,811 |
2,726 |
2,689 |
|
|
|
|
|
|
Average customer assets |
£m |
£m |
£m |
£m |
£m |
Barclays UK |
208,305 |
204,793 |
198,616 |
199,529 |
201,669 |
Barclays UK Corporate Bank |
24,605 |
23,450 |
23,049 |
22,474 |
22,257 |
Barclays Private Bank and Wealth Management |
14,674 |
14,381 |
14,061 |
13,931 |
13,593 |
Barclays US Consumer Bank1 |
26,106 |
25,314 |
24,798 |
24,899 |
24,880 |
Group excluding IB and Head Office |
273,690 |
267,938 |
260,524 |
260,833 |
262,399 |
|
|
|
|
|
|
Net interest margin |
% |
% |
% |
% |
% |
Barclays UK |
3.55 |
3.53 |
3.34 |
3.22 |
3.09 |
Barclays UK Corporate Bank |
5.64 |
5.50 |
5.33 |
5.30 |
5.00 |
Barclays Private Bank and Wealth Management |
5.64 |
5.98 |
5.35 |
5.40 |
5.17 |
Barclays US Consumer Bank |
10.53 |
10.66 |
10.38 |
10.43 |
11.12 |
Group excluding IB and Head Office |
4.51 |
4.50 |
4.29 |
4.20 |
4.12 |
1 |
Average customer assets includes held for sale balances generating net interest income. |
Structural hedge
The Group employs a structural hedge programme designed to stabilise NIM on fixed rate non-maturity balance sheet items that are behaviourally stable. As interest rates move, such balances would otherwise drive material income volatility where there is a re-pricing mismatch with floating rate assets.
The structural hedge predominantly covers non-interest-bearing current accounts and the fixed portion of instant access savings accounts as well as equity, which are invested into either floating rate customer assets or balances at central banks, creating an exposure to changes in interest rates. The structural hedge is executed via a portfolio of receive-fixed, pay variable interest rate swaps, with an amortising structure so that a small portion matures and is reinvested each month at prevailing market rates. The pay-floating leg of the interest rate swaps nets down a proportion of the receive-floating income from the customer assets, leaving a receive-fixed income stream from the structural hedge.
The purpose of the structural hedge is to smooth the Group NII through time. The floating leg of the swap will re-price immediately, whereas the fixed rate yield on the portfolio reprices gradually, as a portion of the swap portfolio matures and the roll is re-invested onto new market rates.
When interest rates are higher than our structural hedge yield, the pay-floating rate will typically be higher than our average receive-fixed rate. In this scenario, when viewed in isolation, the structural hedge will be a net drag to Group NII. When floating rates are lower than our structural hedge yield, the hedge in isolation will be a net benefit.
Since the receive-fixed swaps are booked for a specific term, an element of NII is 'locked in'. The income stabilising feature of the structural hedge provides greater net interest income certainty through the interest rate cycle.
The structural hedge is one component of a larger portfolio of interest rate risk management activities that includes non-structural hedging (e.g. pay-fixed and receive-variable flows for asset hedging), and other offsetting flows. The net risk of these positions is executed externally through interest rate swaps and managed for accounting risk (i.e. income volatility arising from the accounting mismatch of swaps at fair value through profit and loss and underlying hedged items at amortised cost) within the cash flow hedge reserve.
Overall the Group has external derivatives designated as cash flow hedges that hedge interest rate risk with a notional £103.7bn (December 2024: £105.6bn) which reflects the structural hedge notional of £232.2bn (December 2024: £232.3bn) netted with non-structural hedging positions of £128.5bn (December 2024: £126.7bn). The majority of these interest rate swaps are cleared with Central Clearing Counterparties and margined daily with an average structural hedge duration of 3 years.
Gross structural hedge contributions in Q125 were £1,335m (Q124: £1,066m). Gross structural hedge contributions represent the absolute interest income earned on the fixed legs of the swaps in the structural hedge as the floating leg is offset by the base rate funding of the deposits.
Credit Risk
Loans and advances at amortised cost by geography
Total loans and advances at amortised cost in the credit risk performance section includes loans and advances at amortised cost to banks and loans and advances at amortised cost to customers.
The table below presents a product and geographical breakdown by stages of loans and advances at amortised cost and the impairment allowance, including purchased or originated credit-impaired (POCI) balances. POCI balances represent a fixed pool of assets purchased at a deep discount to face value reflecting credit losses incurred from the point of origination to date of acquisition. Also included are stage allocation of debt securities and off-balance sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage ratio.
Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to gross loans and advances to the extent allowance does not exceed the drawn exposure and any excess is reported on the liabilities side of the balance sheet as a provision. For corporate portfolios, impairment allowance on undrawn exposure is reported on the liability side of the balance sheet as a provision.
|
Gross exposure |
|
Impairment allowance |
||||||||
|
Stage 1 |
Stage 2 |
Stage 3 excluding POCI |
Stage 3 POCI |
Total |
|
Stage 1 |
Stage 2 |
Stage 3 excluding POCI |
Stage 3 POCI |
Total |
As at 31.03.25 |
£m |
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
£m |
£m |
Retail mortgages |
148,158 |
18,717 |
1,851 |
- |
168,726 |
|
33 |
61 |
62 |
- |
156 |
Retail credit cards |
13,308 |
2,244 |
208 |
32 |
15,792 |
|
170 |
492 |
109 |
- |
771 |
Retail other |
10,194 |
1,517 |
280 |
15 |
12,006 |
|
117 |
151 |
157 |
- |
425 |
Corporate loans1 |
53,850 |
6,914 |
2,049 |
- |
62,813 |
|
139 |
210 |
386 |
- |
735 |
Total UK |
225,510 |
29,392 |
4,388 |
47 |
259,337 |
|
459 |
914 |
714 |
- |
2,087 |
Retail mortgages |
1,617 |
102 |
172 |
- |
1,891 |
|
2 |
- |
24 |
- |
26 |
Retail credit cards |
16,389 |
2,855 |
1,761 |
- |
21,005 |
|
317 |
816 |
1,409 |
- |
2,542 |
Retail other |
1,981 |
167 |
149 |
- |
2,297 |
|
3 |
2 |
23 |
- |
28 |
Corporate loans |
63,481 |
4,274 |
872 |
- |
68,627 |
|
73 |
157 |
196 |
- |
426 |
Total Rest of the World |
83,468 |
7,398 |
2,954 |
- |
93,820 |
|
395 |
975 |
1,652 |
- |
3,022 |
Total loans and advances at amortised cost |
308,978 |
36,790 |
7,342 |
47 |
353,157 |
|
854 |
1,889 |
2,366 |
- |
5,109 |
Debt securities at amortised cost |
68,404 |
2,994 |
- |
- |
71,398 |
|
10 |
19 |
- |
- |
29 |
Total loans and advances at amortised cost including debt securities |
377,382 |
39,784 |
7,342 |
47 |
424,555 |
|
864 |
1,908 |
2,366 |
- |
5,138 |
Off-balance sheet loan commitments and financial guarantee contracts2 |
404,967 |
17,861 |
1,040 |
6 |
423,874 |
|
176 |
244 |
25 |
- |
445 |
Total3,4 |
782,349 |
57,645 |
8,382 |
53 |
848,429 |
|
1,040 |
2,152 |
2,391 |
- |
5,583 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net exposure |
|
Coverage ratio |
||||||||
|
Stage 1 |
Stage 2 |
Stage 3 excluding POCI |
Stage 3 POCI |
Total |
|
Stage 1 |
Stage 2 |
Stage 3 excluding POCI |
Stage 3 POCI |
Total |
As at 31.03.25 |
£m |
£m |
£m |
£m |
£m |
|
% |
% |
% |
% |
% |
Retail mortgages |
148,125 |
18,656 |
1,789 |
- |
168,570 |
|
- |
0.3 |
3.3 |
- |
0.1 |
Retail credit cards |
13,138 |
1,752 |
99 |
32 |
15,021 |
|
1.3 |
21.9 |
52.4 |
- |
4.9 |
Retail other |
10,077 |
1,366 |
123 |
15 |
11,581 |
|
1.1 |
10.0 |
56.1 |
- |
3.5 |
Corporate loans1 |
53,711 |
6,704 |
1,663 |
- |
62,078 |
|
0.3 |
3.0 |
18.8 |
- |
1.2 |
Total UK |
225,051 |
28,478 |
3,674 |
47 |
257,250 |
|
0.2 |
3.1 |
16.3 |
- |
0.8 |
Retail mortgages |
1,615 |
102 |
148 |
- |
1,865 |
|
0.1 |
- |
14.0 |
- |
1.4 |
Retail credit cards |
16,072 |
2,039 |
352 |
- |
18,463 |
|
1.9 |
28.6 |
80.0 |
- |
12.1 |
Retail other |
1,978 |
165 |
126 |
- |
2,269 |
|
0.2 |
1.2 |
15.4 |
- |
1.2 |
Corporate loans |
63,408 |
4,117 |
676 |
- |
68,201 |
|
0.1 |
3.7 |
22.5 |
- |
0.6 |
Total Rest of the World |
83,073 |
6,423 |
1,302 |
- |
90,798 |
|
0.5 |
13.2 |
55.9 |
- |
3.2 |
Total loans and advances at amortised cost |
308,124 |
34,901 |
4,976 |
47 |
348,048 |
|
0.3 |
5.1 |
32.2 |
- |
1.4 |
Debt securities at amortised cost |
68,394 |
2,975 |
- |
- |
71,369 |
|
- |
0.6 |
- |
- |
- |
Total loans and advances at amortised cost including debt securities |
376,518 |
37,876 |
4,976 |
47 |
419,417 |
|
0.2 |
4.8 |
32.2 |
- |
1.2 |
Off-balance sheet loan commitments and financial guarantee contracts2 |
404,791 |
17,617 |
1,015 |
6 |
423,429 |
|
- |
1.4 |
2.4 |
- |
0.1 |
Total3,4 |
781,309 |
55,493 |
5,991 |
53 |
842,846 |
|
0.1 |
3.7 |
28.5 |
- |
0.7 |
1 |
Includes Business Banking, which has a gross exposure of £12.9bn and an impairment allowance of £342m. This comprises £60m impairment allowance on £8.8bn Stage 1 exposure, £59m on £2.7bn Stage 2 exposure and £223m on £1.4bn Stage 3 exposure. Excluding this, total coverage for corporate loans in UK is 0.8%. |
2 |
Excludes loan commitments and financial guarantees of £21.3bn carried at fair value and includes exposures relating to financial assets classified as assets held for sale. |
3 |
Other financial assets subject to impairment excluded in the table above include cash collateral and settlement balances, reverse repurchase agreements and other similar secured lending, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £248.8bn and an impairment allowance of £158m. This comprises £23m impairment allowance on £247.3bn Stage 1 exposure, £7m on £1.4bn Stage 2 exposure and £128m on £138m Stage 3 exposure. |
4 |
The annualised loan loss rate is 61bps after applying the total impairment charge of £643m. |
|
Gross exposure |
|
Impairment allowance |
||||||||
|
Stage 1 |
Stage 2 |
Stage 3 excluding POCI |
Stage 3 POCI |
Total |
|
Stage 1 |
Stage 2 |
Stage 3 excluding POCI |
Stage 3 POCI |
Total |
As at 31.12.24 |
£m |
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
£m |
£m |
Retail mortgages |
145,039 |
19,507 |
1,793 |
- |
166,339 |
|
36 |
61 |
61 |
- |
158 |
Retail credit cards |
13,497 |
2,064 |
179 |
40 |
15,780 |
|
219 |
440 |
91 |
- |
750 |
Retail other |
10,606 |
1,218 |
257 |
17 |
12,098 |
|
135 |
110 |
138 |
- |
383 |
Corporate loans1 |
52,284 |
7,266 |
2,171 |
- |
61,721 |
|
133 |
196 |
420 |
- |
749 |
Total UK |
221,426 |
30,055 |
4,400 |
57 |
255,938 |
|
523 |
807 |
710 |
- |
2,040 |
Retail mortgages |
1,651 |
89 |
169 |
- |
1,909 |
|
2 |
1 |
26 |
- |
29 |
Retail credit cards |
17,629 |
2,953 |
1,724 |
- |
22,306 |
|
334 |
807 |
1,416 |
- |
2,557 |
Retail other |
1,844 |
155 |
121 |
- |
2,120 |
|
3 |
1 |
23 |
- |
27 |
Corporate loans |
64,224 |
3,901 |
945 |
- |
69,070 |
|
76 |
135 |
206 |
- |
417 |
Total Rest of the World |
85,348 |
7,098 |
2,959 |
- |
95,405 |
|
415 |
944 |
1,671 |
- |
3,030 |
Total loans and advances at amortised cost |
306,774 |
37,153 |
7,359 |
57 |
351,343 |
|
938 |
1,751 |
2,381 |
- |
5,070 |
Debt securities at amortised cost |
64,988 |
3,245 |
- |
- |
68,233 |
|
12 |
11 |
- |
- |
23 |
Total loans and advances at amortised cost including debt securities |
371,762 |
40,398 |
7,359 |
57 |
419,576 |
|
950 |
1,762 |
2,381 |
- |
5,093 |
Off-balance sheet loan commitments and financial guarantee contracts2 |
412,255 |
18,728 |
1,168 |
6 |
432,157 |
|
164 |
250 |
25 |
- |
439 |
Total3,4 |
784,017 |
59,126 |
8,527 |
63 |
851,733 |
|
1,114 |
2,012 |
2,406 |
- |
5,532 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net exposure |
|
Coverage ratio |
||||||||
|
Stage 1 |
Stage 2 |
Stage 3 excluding POCI |
Stage 3 POCI |
Total |
|
Stage 1 |
Stage 2 |
Stage 3 excluding POCI |
Stage 3 POCI |
Total |
As at 31.12.24 |
£m |
£m |
£m |
£m |
£m |
|
% |
% |
% |
% |
% |
Retail mortgages |
145,003 |
19,446 |
1,732 |
- |
166,181 |
|
- |
0.3 |
3.4 |
- |
0.1 |
Retail credit cards |
13,278 |
1,624 |
88 |
40 |
15,030 |
|
1.6 |
21.3 |
50.8 |
- |
4.8 |
Retail other |
10,471 |
1,108 |
119 |
17 |
11,715 |
|
1.3 |
9.0 |
53.7 |
- |
3.2 |
Corporate loans1 |
52,151 |
7,070 |
1,751 |
- |
60,972 |
|
0.3 |
2.7 |
19.3 |
- |
1.2 |
Total UK |
220,903 |
29,248 |
3,690 |
57 |
253,898 |
|
0.2 |
2.7 |
16.1 |
- |
0.8 |
Retail mortgages |
1,649 |
88 |
143 |
- |
1,880 |
|
0.1 |
1.1 |
15.4 |
- |
1.5 |
Retail credit cards |
17,295 |
2,146 |
308 |
- |
19,749 |
|
1.9 |
27.3 |
82.1 |
- |
11.5 |
Retail other |
1,841 |
154 |
98 |
- |
2,093 |
|
0.2 |
0.6 |
19.0 |
- |
1.3 |
Corporate loans |
64,148 |
3,766 |
739 |
- |
68,653 |
|
0.1 |
3.5 |
21.8 |
- |
0.6 |
Total Rest of the World |
84,933 |
6,154 |
1,288 |
- |
92,375 |
|
0.5 |
13.3 |
56.5 |
- |
3.2 |
Total loans and advances at amortised cost |
305,836 |
35,402 |
4,978 |
57 |
346,273 |
|
0.3 |
4.7 |
32.4 |
- |
1.4 |
Debt securities at amortised cost |
64,976 |
3,234 |
- |
- |
68,210 |
|
- |
0.3 |
- |
- |
- |
Total loans and advances at amortised cost including debt securities |
370,812 |
38,636 |
4,978 |
57 |
414,483 |
|
0.3 |
4.4 |
32.4 |
- |
1.2 |
Off-balance sheet loan commitments and financial guarantee contracts2 |
412,091 |
18,478 |
1,143 |
6 |
431,718 |
|
- |
1.3 |
2.1 |
- |
0.1 |
Total3,4 |
782,903 |
57,114 |
6,121 |
63 |
846,201 |
|
0.1 |
3.4 |
28.2 |
- |
0.6 |
1 |
Includes Business Banking, which has a gross exposure of £13.1bn and an impairment allowance of £356m. This comprises £60m impairment allowance on £8.9bn Stage 1 exposure, £60m on £2.8bn Stage 2 exposure and £236m on £1.5bn Stage 3 exposure. Excluding this, total coverage for corporate loans in UK is 0.8%. |
2 |
Excludes loan commitments and financial guarantees of £16.3bn carried at fair value and includes exposures relating to financial assets classified as assets held for sale. |
3 |
Other financial assets subject to impairment excluded in the table above include cash collateral and settlement balances, reverse repurchase agreements and other similar secured lending, financial assets at fair value through other comprehensive income and other assets. These have a total gross exposure of £204.2bn and an impairment allowance of £156m. This comprises £19m impairment allowance on £202.7bn Stage 1 exposure, £7m on £1.3bn Stage 2 exposure and £130m on £139m Stage 3 exposure. |
4 |
The annualised loan loss rate is 46bps after applying the total impairment charge of £1,982m. |
Assets held for sale
This table presents a co-branded card portfolio in USCB classified as assets held for sale. Further, the sale of the German consumer finance business was completed in early Q125.
Loans and advances to customers classified as assets held for sale |
|||||||||||||||
|
Stage 1 |
|
Stage 2 |
|
Stage 3 |
|
Total |
||||||||
|
Gross |
ECL |
Coverage |
|
Gross |
ECL |
Coverage |
|
Gross |
ECL |
Coverage |
|
Gross |
ECL |
Coverage |
As at 31.03.25 |
£m |
£m |
% |
|
£m |
£m |
% |
|
£m |
£m |
% |
|
£m |
£m |
% |
Retail credit cards - US |
5,102 |
59 |
1.2 |
|
660 |
148 |
22.4 |
|
58 |
46 |
79.3 |
|
5,820 |
253 |
4.3 |
Retail credit cards - Germany |
- |
- |
- |
|
- |
- |
- |
|
- |
- |
- |
|
- |
- |
- |
Retail other - Germany |
- |
- |
- |
|
- |
- |
- |
|
- |
- |
- |
|
- |
- |
- |
Corporate loans - US |
47 |
1 |
2.1 |
|
8 |
3 |
37.5 |
|
1 |
1 |
100.0 |
|
56 |
5 |
8.9 |
Total Rest of the World |
5,149 |
60 |
1.2 |
|
668 |
151 |
22.6 |
|
59 |
47 |
79.7 |
|
5,876 |
258 |
4.4 |
As at 31.12.24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retail credit cards - US |
5,495 |
64 |
1.2 |
|
689 |
161 |
23.4 |
|
57 |
46 |
80.7 |
|
6,241 |
271 |
4.3 |
Retail credit cards - Germany |
1,908 |
18 |
0.9 |
|
307 |
29 |
9.4 |
|
93 |
69 |
74.2 |
|
2,308 |
116 |
5.0 |
Retail other - Germany |
1,134 |
16 |
1.4 |
|
220 |
33 |
15.0 |
|
71 |
48 |
67.6 |
|
1,425 |
97 |
6.8 |
Corporate loans - US |
49 |
1 |
2.0 |
|
9 |
3 |
33.3 |
|
1 |
1 |
100.0 |
|
59 |
5 |
8.5 |
Total Rest of the World |
8,586 |
99 |
1.2 |
|
1,225 |
226 |
18.4 |
|
222 |
164 |
73.9 |
|
10,033 |
489 |
4.9 |
Loans and advances at amortised cost by product
The table below presents a product breakdown by stages of loans and advances at amortised cost. Also included is a breakdown of Stage 2 past due balances.
|
|
Stage 2 |
|
|
|
|||
As at 31.03.25 |
Stage 1 |
Not past due |
<=30 days past due |
>30 days past due |
Total |
Stage 3 excluding POCI |
Stage 3 POCI |
Total |
Gross exposure |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
Retail mortgages |
149,775 |
16,046 |
2,062 |
711 |
18,819 |
2,023 |
- |
170,617 |
Retail credit cards |
29,697 |
4,492 |
322 |
285 |
5,099 |
1,969 |
32 |
36,797 |
Retail other |
12,175 |
1,263 |
204 |
217 |
1,684 |
429 |
15 |
14,303 |
Corporate loans |
117,331 |
11,070 |
31 |
87 |
11,188 |
2,921 |
- |
131,440 |
Total |
308,978 |
32,871 |
2,619 |
1,300 |
36,790 |
7,342 |
47 |
353,157 |
|
|
|
|
|
|
|
|
|
Impairment allowance |
|
|
|
|
|
|
|
|
Retail mortgages |
35 |
37 |
14 |
10 |
61 |
86 |
- |
182 |
Retail credit cards |
487 |
1,021 |
123 |
164 |
1,308 |
1,518 |
- |
3,313 |
Retail other |
120 |
105 |
24 |
24 |
153 |
180 |
- |
453 |
Corporate loans |
212 |
349 |
8 |
10 |
367 |
582 |
- |
1,161 |
Total |
854 |
1,512 |
169 |
208 |
1,889 |
2,366 |
- |
5,109 |
|
|
|
|
|
|
|
|
|
Net exposure |
|
|
|
|
|
|
|
|
Retail mortgages |
149,740 |
16,009 |
2,048 |
701 |
18,758 |
1,937 |
- |
170,435 |
Retail credit cards |
29,210 |
3,471 |
199 |
121 |
3,791 |
451 |
32 |
33,484 |
Retail other |
12,055 |
1,158 |
180 |
193 |
1,531 |
249 |
15 |
13,850 |
Corporate loans |
117,119 |
10,721 |
23 |
77 |
10,821 |
2,339 |
- |
130,279 |
Total |
308,124 |
31,359 |
2,450 |
1,092 |
34,901 |
4,976 |
47 |
348,048 |
|
|
|
|
|
|
|
|
|
Coverage ratio |
% |
% |
% |
% |
% |
% |
% |
% |
Retail mortgages |
- |
0.2 |
0.7 |
1.4 |
0.3 |
4.3 |
- |
0.1 |
Retail credit cards |
1.6 |
22.7 |
38.2 |
57.5 |
25.7 |
77.1 |
- |
9.0 |
Retail other |
1.0 |
8.3 |
11.8 |
11.1 |
9.1 |
42.0 |
- |
3.2 |
Corporate loans |
0.2 |
3.2 |
25.8 |
11.5 |
3.3 |
19.9 |
- |
0.9 |
Total |
0.3 |
4.6 |
6.5 |
16.0 |
5.1 |
32.2 |
- |
1.4 |
As at 31.12.24 |
|
|
|
|
|
|
|
|
Gross exposure |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
Retail mortgages |
146,690 |
16,790 |
2,034 |
772 |
19,596 |
1,962 |
- |
168,248 |
Retail credit cards |
31,126 |
4,435 |
303 |
279 |
5,017 |
1,903 |
40 |
38,086 |
Retail other |
12,450 |
1,056 |
211 |
106 |
1,373 |
378 |
17 |
14,218 |
Corporate loans |
116,508 |
10,849 |
144 |
174 |
11,167 |
3,116 |
- |
130,791 |
Total |
306,774 |
33,130 |
2,692 |
1,331 |
37,153 |
7,359 |
57 |
351,343 |
|
|
|
|
|
|
|
|
|
Impairment allowance |
|
|
|
|
|
|
|
|
Retail mortgages |
38 |
42 |
13 |
7 |
62 |
87 |
- |
187 |
Retail credit cards |
553 |
959 |
122 |
166 |
1,247 |
1,507 |
- |
3,307 |
Retail other |
138 |
76 |
17 |
18 |
111 |
161 |
- |
410 |
Corporate loans |
209 |
316 |
7 |
8 |
331 |
626 |
- |
1,166 |
Total |
938 |
1,393 |
159 |
199 |
1,751 |
2,381 |
- |
5,070 |
|
|
|
|
|
|
|
|
|
Net exposure |
|
|
|
|
|
|
|
|
Retail mortgages |
146,652 |
16,748 |
2,021 |
765 |
19,534 |
1,875 |
- |
168,061 |
Retail credit cards |
30,573 |
3,476 |
181 |
113 |
3,770 |
396 |
40 |
34,779 |
Retail other |
12,312 |
980 |
194 |
88 |
1,262 |
217 |
17 |
13,808 |
Corporate loans |
116,299 |
10,533 |
137 |
166 |
10,836 |
2,490 |
- |
129,625 |
Total |
305,836 |
31,737 |
2,533 |
1,132 |
35,402 |
4,978 |
57 |
346,273 |
|
|
|
|
|
|
|
|
|
Coverage ratio |
% |
% |
% |
% |
% |
% |
% |
% |
Retail mortgages |
- |
0.3 |
0.6 |
0.9 |
0.3 |
4.4 |
- |
0.1 |
Retail credit cards |
1.8 |
21.6 |
40.3 |
59.5 |
24.9 |
79.2 |
- |
8.7 |
Retail other |
1.1 |
7.2 |
8.1 |
17.0 |
8.1 |
42.6 |
- |
2.9 |
Corporate loans |
0.2 |
2.9 |
4.9 |
4.6 |
3.0 |
20.1 |
- |
0.9 |
Total |
0.3 |
4.2 |
5.9 |
15.0 |
4.7 |
32.4 |
- |
1.4 |
Measurement uncertainty
Scenarios used to calculate the Group's ECL charge were refreshed in Q125 with the Baseline scenario reflecting the latest consensus macroeconomic forecasts available at the time of the scenario refresh. In the Baseline scenario, following a somewhat encouraging 2024, the growth in the UK economy is gradually slowing when compared to consensus at FY24, though restrictive monetary policy continues to loosen. UK and US GDP growth in 2025 is expected to be 1.0% and 2.4%, respectively. Labour markets in major economies remain broadly resilient with unemployment rates relatively close to historic lows and are only expected to increase moderately. The UK unemployment rate peaks at 4.5% where it remains for most of the 5-year projection period. US unemployment peaks at 4.3%. The Bank of England cuts rates by 25bps three times in 2025 and once more in 2026. The Fed follows a slower pace of monetary policy loosening and finishes 2025 with rates at 4.3%. As lower rates feed into new mortgages, UK house prices stabilise and resume the upward trend from 2025. US house prices continue to grow at a decent pace.
The Downside 2 scenario has been broadly aligned to the Group's 2024 Internal Stress Test. Under this scenario, the restrictive monetary policy seen over the last few years coupled with a loss of consumer and business confidence amid persistent inflation leads to a sharp contraction in economic activity. A sustained drop in consumer spending due to high household debt levels and affordability loss amid stagnant wages leads to a significant reduction in aggregate demand. The economic slowdown leads to rising unemployment rates as lay-offs intensify. UK and US unemployment peaks at 8.4% and 7.5% respectively, during 2026. In order to support the economy, Central banks start to reduce rates. In the Upside 2 scenario, a rise in labour force participation and higher productivity contribute to accelerated economic growth, without creating new inflationary pressures. Central banks lower interest rates stimulating private consumption and investment growth. Demand for labour increases and unemployment rates stabilise and start falling again. As geopolitical tensions ease, low inflation supports consumer purchasing power and contributes further to a healthy GDP growth. The strong economic outlook and lower interest rates provide a boost to house prices growth and support bullish financial markets.
The methodology for estimating scenario probability weights involves simulating a range of future paths for UK and US GDP using historical data with the five scenarios mapped against the distribution of these future paths. The median is centred around the Baseline with scenarios further from the Baseline attracting a lower weighting before the five weights are normalised to total 100%. The increases in the Upside scenario weightings were driven by the improvement in US GDP in the Baseline scenario, bringing the Baseline scenario closer to the Upside scenarios. For further details see page 32.
The Group continues to monitor the heightened uncertainty in the near-term macroeconomic outlook, especially in the US. The broadening range of outcomes coupled with a perceived lag in consensus suggests that a greater weighting than that used in the modelled ECL output (see below) should be applied to the Group's Downside scenarios to reflect the macroeconomic uncertainty. In response, a gross £91m uncertainty PMA (a £74m income statement impact net of SRT credit protection1) has been booked in Q125 across the US Consumer Bank (£38m) and the Investment Bank (gross/net SRT1 £53m/£36m). This adjustment reflects a point in time impact based on the balance sheet as at 31 March 2025 for the uncertainty around macroeconomic variables. It does not factor in future changes in customer utilisation or management actions the Group might take to mitigate credit risk.
The following tables show the key macroeconomic variables used in the five scenarios (5-year annual paths) and the probability weights applied to each scenario.
1 |
Significant Risk Transfer (SRT) represents risk transfer transactions used to enhance Barclays' risk management capabilities. |
Macroeconomic variables used in the calculation of ECL |
|||||
As at 31.03.25 |
2025 |
2026 |
2027 |
2028 |
2029 |
Baseline |
% |
% |
% |
% |
% |
UK GDP1 |
1.0 |
1.4 |
1.4 |
1.4 |
1.4 |
UK unemployment2 |
4.5 |
4.4 |
4.5 |
4.5 |
4.5 |
UK HPI3 |
2.3 |
2.2 |
4.1 |
3.4 |
3.8 |
UK bank rate6 |
4.2 |
3.9 |
3.8 |
3.8 |
3.8 |
US GDP1 |
2.4 |
2.0 |
2.0 |
2.0 |
2.0 |
US unemployment4 |
4.2 |
4.2 |
4.2 |
4.2 |
4.2 |
US HPI5 |
2.8 |
2.7 |
2.9 |
3.0 |
3.0 |
US federal funds rate6 |
4.3 |
4.3 |
4.3 |
4.3 |
4.3 |
|
|
|
|
|
|
Downside 2 |
|
|
|
|
|
UK GDP1 |
(1.3) |
(2.8) |
2.3 |
2.5 |
1.4 |
UK unemployment2 |
5.4 |
8.0 |
7.0 |
5.6 |
5.2 |
UK HPI3 |
(16.8) |
(13.9) |
4.6 |
17.4 |
8.3 |
UK bank rate6 |
4.0 |
2.2 |
0.6 |
0.9 |
1.7 |
US GDP1 |
0.5 |
(2.8) |
3.0 |
3.0 |
1.8 |
US unemployment4 |
5.1 |
7.3 |
6.4 |
5.6 |
5.1 |
US HPI5 |
(4.7) |
(3.9) |
4.0 |
5.0 |
3.5 |
US federal funds rate6 |
3.4 |
0.7 |
0.6 |
1.3 |
2.1 |
|
|
|
|
|
|
Downside 1 |
|
|
|
|
|
UK GDP1 |
(0.1) |
(0.7) |
1.9 |
1.9 |
1.4 |
UK unemployment2 |
4.9 |
6.2 |
5.8 |
5.1 |
4.8 |
UK HPI3 |
(7.6) |
(6.0) |
4.4 |
10.2 |
6.0 |
UK bank rate6 |
4.1 |
3.1 |
2.3 |
2.4 |
2.8 |
US GDP1 |
1.5 |
(0.4) |
2.5 |
2.5 |
1.9 |
US unemployment4 |
4.7 |
5.7 |
5.3 |
4.9 |
4.6 |
US HPI5 |
(0.9) |
(0.6) |
3.5 |
4.0 |
3.2 |
US federal funds rate6 |
3.9 |
2.5 |
2.3 |
2.6 |
3.2 |
|
|
|
|
|
|
Upside 2 |
|
|
|
|
|
UK GDP1 |
1.8 |
4.0 |
3.1 |
2.5 |
2.3 |
UK unemployment2 |
4.1 |
3.8 |
3.6 |
3.6 |
3.6 |
UK HPI3 |
8.7 |
11.0 |
5.8 |
3.4 |
3.0 |
UK bank rate6 |
4.0 |
3.1 |
2.5 |
2.7 |
2.8 |
US GDP1 |
2.8 |
3.2 |
2.8 |
2.8 |
2.8 |
US unemployment4 |
3.9 |
3.5 |
3.5 |
3.5 |
3.5 |
US HPI5 |
6.2 |
4.2 |
4.9 |
4.9 |
4.9 |
US federal funds rate6 |
4.1 |
3.5 |
3.5 |
3.4 |
3.3 |
|
|
|
|
|
|
Upside 1 |
|
|
|
|
|
UK GDP1 |
1.4 |
2.7 |
2.2 |
1.9 |
1.9 |
UK unemployment2 |
4.3 |
4.1 |
4.1 |
4.1 |
4.1 |
UK HPI3 |
5.5 |
6.6 |
4.9 |
3.4 |
3.4 |
UK bank rate6 |
4.1 |
3.5 |
3.3 |
3.3 |
3.3 |
US GDP1 |
2.6 |
2.6 |
2.4 |
2.4 |
2.4 |
US unemployment4 |
4.0 |
3.8 |
3.8 |
3.8 |
3.8 |
US HPI5 |
4.5 |
3.4 |
3.9 |
3.9 |
3.9 |
US federal funds rate6 |
4.2 |
3.8 |
3.8 |
3.8 |
3.8 |
1 |
Average Real GDP seasonally adjusted change in year. |
2 |
Average UK unemployment rate 16-year+. |
3 |
Change in year end UK HPI = Halifax HPI Meth2 All Houses, All Buyers index. |
4 |
Average US civilian unemployment rate 16-year+. |
5 |
Change in year end US HPI = FHFA House Price Index, relative to prior year end. |
6 |
Average rate. |
As at 31.12.24 |
2024 |
2025 |
2026 |
2027 |
2028 |
Baseline |
% |
% |
% |
% |
% |
UK GDP1 |
1.0 |
1.4 |
1.5 |
1.6 |
1.5 |
UK unemployment2 |
4.3 |
4.4 |
4.5 |
4.4 |
4.4 |
UK HPI3 |
2.8 |
3.3 |
1.6 |
4.5 |
3.0 |
UK bank rate6 |
5.1 |
4.3 |
4.0 |
4.0 |
3.8 |
US GDP1 |
2.7 |
2.0 |
2.0 |
2.0 |
2.0 |
US unemployment4 |
4.1 |
4.3 |
4.2 |
4.2 |
4.2 |
US HPI5 |
6.5 |
2.6 |
2.7 |
3.0 |
3.0 |
US federal funds rate6 |
5.1 |
4.1 |
4.0 |
3.8 |
3.8 |
|
|
|
|
|
|
Downside 2 |
|
|
|
|
|
UK GDP1 |
1.0 |
(2.3) |
(1.3) |
2.6 |
2.3 |
UK unemployment2 |
4.3 |
6.2 |
8.1 |
6.6 |
5.5 |
UK HPI3 |
2.8 |
(24.8) |
(5.2) |
10.0 |
14.6 |
UK bank rate6 |
5.1 |
3.5 |
1.7 |
0.6 |
1.1 |
US GDP1 |
2.7 |
(1.3) |
(1.3) |
3.3 |
2.9 |
US unemployment4 |
4.1 |
5.8 |
7.2 |
6.2 |
5.5 |
US HPI5 |
6.5 |
(8.0) |
(0.7) |
5.2 |
4.0 |
US federal funds rate6 |
5.1 |
2.5 |
0.6 |
0.8 |
1.5 |
|
|
|
|
|
|
Downside 1 |
|
|
|
|
|
UK GDP1 |
1.0 |
(0.5) |
0.1 |
2.1 |
1.9 |
UK unemployment2 |
4.3 |
5.3 |
6.3 |
5.5 |
5.0 |
UK HPI3 |
2.8 |
(11.6) |
(1.8) |
7.2 |
8.7 |
UK bank rate6 |
5.1 |
3.9 |
2.9 |
2.3 |
2.4 |
US GDP1 |
2.7 |
0.3 |
0.4 |
2.7 |
2.4 |
US unemployment4 |
4.1 |
5.1 |
5.7 |
5.2 |
4.9 |
US HPI5 |
6.5 |
(2.7) |
1.0 |
4.1 |
3.5 |
US federal funds rate6 |
5.1 |
3.4 |
2.3 |
2.3 |
2.7 |
|
|
|
|
|
|
Upside 2 |
|
|
|
|
|
UK GDP1 |
1.0 |
3.0 |
3.7 |
2.9 |
2.4 |
UK unemployment2 |
4.3 |
3.8 |
3.4 |
3.5 |
3.5 |
UK HPI3 |
2.8 |
11.9 |
8.4 |
5.1 |
4.1 |
UK bank rate6 |
5.1 |
3.9 |
2.9 |
2.8 |
2.8 |
US GDP1 |
2.7 |
2.8 |
3.1 |
2.8 |
2.8 |
US unemployment4 |
4.1 |
3.8 |
3.5 |
3.5 |
3.5 |
US HPI5 |
6.5 |
6.2 |
4.7 |
4.8 |
4.9 |
US federal funds rate6 |
5.1 |
3.7 |
3.3 |
3.1 |
2.8 |
|
|
|
|
|
|
Upside 1 |
|
|
|
|
|
UK GDP1 |
1.0 |
2.2 |
2.6 |
2.2 |
2.0 |
UK unemployment2 |
4.3 |
4.1 |
4.0 |
4.0 |
4.0 |
UK HPI3 |
2.8 |
7.6 |
4.9 |
4.8 |
3.5 |
UK bank rate6 |
5.1 |
4.1 |
3.5 |
3.4 |
3.3 |
US GDP1 |
2.7 |
2.4 |
2.6 |
2.4 |
2.4 |
US unemployment4 |
4.1 |
4.0 |
3.9 |
3.9 |
3.9 |
US HPI5 |
6.5 |
4.4 |
3.7 |
3.9 |
3.9 |
US federal funds rate6 |
5.1 |
4.0 |
3.8 |
3.6 |
3.3 |
1 |
Average Real GDP seasonally adjusted change in year. |
2 |
Average UK unemployment rate 16-year+. |
3 |
Change in year end UK HPI = Halifax All Houses, All Buyers index, relative to prior year end. |
4 |
Average US civilian unemployment rate 16-year+. |
5 |
Change in year end US HPI = FHFA House Price Index, relative to prior year end. |
6 |
Average rate. |
Scenario probability weighting |
Upside 2 |
Upside 1 |
Baseline |
Downside 1 |
Downside 2 |
|
% |
% |
% |
% |
% |
As at 31.03.25 |
|
|
|
|
|
Scenario probability weighting |
17.6 |
26.8 |
32.6 |
14.4 |
8.6 |
As at 31.12.24 |
|
|
|
|
|
Scenario probability weighting |
17.4 |
26.8 |
32.5 |
14.7 |
8.6 |
Treasury and Capital Risk
Regulatory minimum requirements
Capital
As at 31 March 2025, the Group's Overall Capital Requirement for CET1 increased to 12.2% following the latest PRA Individual Capital Requirement (ICR) notice and comprises a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer (CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.7% Pillar 2A requirement and a 1.0% Countercyclical Capital Buffer (CCyB).
The Group's CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. The buffer rates set by other national authorities for non-UK exposures are not currently material.
The Group's updated Pillar 2A requirement increased by 23bps to 4.8% with at least 56.25% to be met with CET1 capital, equating to 2.7% of RWAs. The Pillar 2A requirement, based on a point in time assessment, has been set as a proportion of RWAs and is subject to at least annual review.
The Group's CET1 target ratio of 13-14% takes into account minimum capital requirements and applicable buffers. The Group remains above its minimum capital regulatory requirements and applicable buffers.
Leverage
As at 31 March 2025, the Group was subject to a UK leverage ratio requirement of 4.1%. This comprises the 3.25% minimum requirement, a G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer (CCLB) of 0.3%. The Group is also required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the quarter and an exposure measure for each day in the quarter.
MREL
As at 31 March 2025, the Group was required to meet the higher of: (i) two times the sum of 8% Pillar 1 and 4.8% Pillar 2A equating to 25.7% of RWAs; and (ii) 6.75% of leverage exposures. In addition, the higher of regulatory capital and leverage buffers apply. CET1 capital cannot be counted towards both MREL and the buffers, meaning that the buffers, including the above mentioned confidential institution-specific PRA buffer, will effectively be applied above MREL requirements.
Capital ratios1,2 |
As at 31.03.25 |
As at 31.12.24 |
CET1 |
13.9% |
13.6% |
T1 |
17.7% |
16.9% |
Total regulatory capital |
20.6% |
19.6% |
MREL ratio as a percentage of total RWAs |
36.2% |
34.4% |
|
|
|
Own funds and eligible liabilities |
£m |
£m |
Total equity excluding non-controlling interests per the balance sheet |
74,880 |
71,821 |
Less: other equity instruments (recognised as AT1 capital) |
(13,263) |
(12,075) |
Adjustment to retained earnings for foreseeable ordinary share dividends |
(1,086) |
(786) |
Adjustment to retained earnings for foreseeable repurchase of shares |
(664) |
- |
Adjustment to retained earnings for foreseeable other equity coupons |
(49) |
(35) |
|
|
|
Other regulatory adjustments and deductions |
|
|
Additional value adjustments (PVA) |
(1,795) |
(2,051) |
Goodwill and intangible assets |
(8,247) |
(8,272) |
Deferred tax assets that rely on future profitability excluding temporary differences |
(1,408) |
(1,451) |
Fair value reserves related to gains or losses on cash flow hedges |
2,378 |
2,930 |
Excess of expected losses over impairment |
(306) |
(403) |
Gains or losses on liabilities at fair value resulting from own credit |
799 |
981 |
Defined benefit pension fund assets |
(2,326) |
(2,367) |
Direct and indirect holdings by an institution of own CET1 instruments |
(4) |
(1) |
Adjustment under IFRS 9 transitional arrangements |
- |
138 |
Other regulatory adjustments |
(115) |
129 |
CET1 capital |
48,794 |
48,558 |
|
|
|
AT1 capital |
|
|
Capital instruments and related share premium accounts |
13,289 |
12,108 |
Other regulatory adjustments and deductions |
(26) |
(32) |
AT1 capital |
13,263 |
12,076 |
|
|
|
T1 capital |
62,057 |
60,634 |
|
|
|
T2 capital |
|
|
Capital instruments and related share premium accounts |
9,988 |
9,150 |
Qualifying T2 capital (including minority interests) issued by subsidiaries |
337 |
367 |
Other regulatory adjustments and deductions |
(43) |
(33) |
Total regulatory capital |
72,339 |
70,118 |
|
|
|
Less : Ineligible T2 capital (including minority interests) issued by subsidiaries |
(337) |
(367) |
Eligible liabilities |
55,159 |
53,547 |
Total own funds and eligible liabilities3 |
127,161 |
123,298 |
|
|
|
Total RWAs |
351,314 |
358,127 |
1 |
Capital and RWAs for 31 December 2024 have been calculated by applying the IFRS 9 transitional arrangements in accordance with UK CRR. Effective from 1 January 2025, the IFRS 9 transitional arrangements no longer applied. |
2 |
Total capital includes the grandfathering of certain capital instruments until 28 June 2025. |
3 |
As at 31 March 2025, the Group's MREL requirement, excluding the PRA buffer, was to hold £107.7bn of own funds and eligible liabilities equating to 30.7% of RWAs. The Group remains above its MREL regulatory requirement including the PRA buffer. |
Movement in CET1 capital |
Three months ended 31.03.25 |
|
£m |
Opening CET1 capital |
48,558 |
|
|
Profit for the period attributable to equity holders |
2,096 |
Own credit relating to derivative liabilities |
(17) |
Ordinary share dividends paid and foreseen |
(300) |
Purchased and foreseeable share repurchase |
(1,000) |
Other equity coupons paid and foreseen |
(246) |
Increase in retained regulatory capital generated from earnings |
533 |
|
|
Net impact of share schemes |
(249) |
Fair value through other comprehensive income reserve |
233 |
Currency translation reserve |
(546) |
Other reserves |
2 |
Decrease in other qualifying reserves |
(560) |
|
|
Pension remeasurements within reserves |
(48) |
Defined benefit pension fund asset deduction |
41 |
Net impact of pensions |
(7) |
|
|
Additional value adjustments (PVA) |
256 |
Goodwill and intangible assets |
25 |
Deferred tax assets that rely on future profitability excluding those arising from temporary differences |
43 |
Excess of expected loss over impairment |
97 |
Direct and indirect holdings by an institution of own CET1 instruments |
(3) |
Adjustment under IFRS 9 transitional arrangements |
(138) |
Other regulatory adjustments |
(10) |
Increase in regulatory capital due to adjustments and deductions |
270 |
|
|
Closing CET1 capital |
48,794 |
CET1 capital increased by £0.2bn to £48.8bn (December 2024: £48.6bn). Significant movements in the period were:
• £2.1bn of capital generated from profit partially offset by distributions of £1.5bn comprising:
- £1.0bn of share buybacks announced with FY24 results
- £0.3bn accrual towards the FY25 dividend
- £0.2bn of equity coupons paid and foreseen
• £0.6bn decrease in other qualifying reserves including a £0.5bn reduction in the currency translation reserve primarily as a result of the strengthening of GBP against USD
RWAs by risk type and business |
|||||||||||||
|
Credit risk |
|
Counterparty credit risk |
|
Market Risk |
|
Operational risk |
Total RWAs |
|||||
|
STD |
IRB |
|
STD |
IRB |
Settlement Risk |
CVA |
|
STD |
IMA |
|
|
|
As at 31.03.25 |
£m |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
|
£m |
£m |
Barclays UK |
15,346 |
56,050 |
|
140 |
5 |
- |
47 |
|
184 |
- |
|
13,196 |
84,968 |
Barclays UK Corporate Bank |
3,780 |
16,213 |
|
105 |
348 |
- |
11 |
|
2 |
471 |
|
3,282 |
24,212 |
Barclays Private Bank & Wealth Management |
5,025 |
495 |
|
127 |
51 |
- |
18 |
|
48 |
330 |
|
1,870 |
7,964 |
Barclays Investment Bank |
40,169 |
45,915 |
|
22,924 |
22,540 |
139 |
3,190 |
|
13,458 |
23,306 |
|
24,293 |
195,934 |
Barclays US Consumer Bank |
19,723 |
993 |
|
- |
- |
- |
- |
|
- |
- |
|
4,856 |
25,572 |
Head Office |
5,516 |
5,808 |
|
1 |
13 |
- |
2 |
|
19 |
82 |
|
1,223 |
12,664 |
Barclays Group |
89,559 |
125,474 |
|
23,297 |
22,957 |
139 |
3,268 |
|
13,711 |
24,189 |
|
48,720 |
351,314 |
As at 31.12.24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Barclays UK |
15,516 |
55,301 |
|
146 |
11 |
- |
74 |
|
228 |
- |
|
13,181 |
84,457 |
Barclays UK Corporate Bank |
3,932 |
15,680 |
|
106 |
336 |
- |
12 |
|
16 |
548 |
|
3,282 |
23,912 |
Barclays Private Bank & Wealth Management |
5,058 |
434 |
|
118 |
31 |
- |
16 |
|
44 |
330 |
|
1,859 |
7,890 |
Barclays Investment Bank |
40,957 |
49,231 |
|
21,889 |
24,094 |
70 |
2,913 |
|
12,442 |
23,023 |
|
24,164 |
198,783 |
Barclays US Consumer Bank |
21,019 |
966 |
|
- |
- |
- |
- |
|
- |
- |
|
4,864 |
26,849 |
Head Office |
6,580 |
8,162 |
|
1 |
20 |
- |
4 |
|
- |
212 |
|
1,257 |
16,236 |
Barclays Group |
93,062 |
129,774 |
|
22,260 |
24,492 |
70 |
3,019 |
|
12,730 |
24,113 |
|
48,607 |
358,127 |
Movement analysis of RWAs |
Credit risk |
Counterparty credit risk |
Market risk |
Operational risk |
Total RWAs |
|
£m |
£m |
£m |
£m |
£m |
Opening RWAs (as at 31.12.24) |
222,836 |
49,841 |
36,843 |
48,607 |
358,127 |
Book size |
(2,343) |
935 |
1,355 |
113 |
60 |
Acquisitions and disposals |
(3,299) |
- |
- |
- |
(3,299) |
Book quality |
(300) |
(246) |
- |
- |
(546) |
Model updates |
- |
- |
- |
- |
- |
Methodology and policy |
29 |
- |
- |
- |
29 |
Foreign exchange movements1 |
(1,890) |
(869) |
(298) |
- |
(3,057) |
Total RWA movements |
(7,803) |
(180) |
1,057 |
113 |
(6,813) |
Closing RWAs (as at 31.03.25) |
215,033 |
49,661 |
37,900 |
48,720 |
351,314 |
1 |
Foreign exchange movements does not include the impact of foreign exchange for modelled market risk or operational risk. |
Overall RWAs decreased £6.8bn to £351.3bn (December 2024: £358.1bn).
Credit risk RWAs decreased £7.8bn:
• A £2.3bn decrease in book size primarily driven by business activity within IB, partially offset by mortgage lending growth within Barclays UK
• A £3.3bn decrease in acquisitions and disposals reflecting the sale of the German Consumer Finance business
• A £1.9bn decrease as a result of foreign exchange movements primarily due to the strengthening of GBP against USD
Market risk RWAs increased £1.1bn:
• A £1.4bn increase in book size due to trading activity within Global Markets
Leverage ratios1 |
As at 31.03.25 |
As at 31.12.24 |
£m |
£m |
|
UK leverage ratio2 |
5.0% |
5.0% |
T1 capital |
62,057 |
60,634 |
UK leverage exposure |
1,252,827 |
1,206,502 |
Average UK leverage ratio |
4.6% |
4.6% |
Average T1 capital |
61,641 |
60,291 |
Average UK leverage exposure |
1,340,481 |
1,308,335 |
1 |
31 December 2024 UK leverage ratios have been calculated by applying the IFRS 9 transitional arrangements in accordance with UK CRR. Effective from 1 January 2025, the IFRS 9 transitional arrangements no longer applied. |
2 |
Although the leverage ratio is expressed in terms of T1 capital, the leverage ratio buffers and 75% of the minimum requirement must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII ALRB was £6.6bn and against the 0.3% CCLB was £3.8bn. |
The UK leverage ratio remained stable at 5.0% (December 2024: 5.0%), as the leverage exposure increased by £46.3bn to £1,252.8bn (December 2024: £1,206.5bn) partially offset by an increase in T1 capital of £1.4bn. The increase in leverage exposure was largely driven by an increase in trading activity in IB.
Condensed Consolidated Financial Statements
Condensed consolidated income statement (unaudited) |
||
|
Three months ended 31.03.25 |
Three months ended 31.03.24 |
|
£m |
£m |
Total income |
7,709 |
6,953 |
Operating expenses excluding UK regulatory levies & litigation and conduct |
(4,258) |
(3,998) |
UK regulatory levies |
(96) |
(120) |
Litigation and conduct |
(11) |
(57) |
Operating expenses |
(4,365) |
(4,175) |
Other net income |
18 |
12 |
Profit before impairment |
3,362 |
2,790 |
Credit impairment charges |
(643) |
(513) |
Profit before tax |
2,719 |
2,277 |
Tax charge |
(621) |
(465) |
Profit after tax |
2,098 |
1,812 |
|
|
|
Attributable to: |
|
|
Shareholders of the parent |
1,864 |
1,550 |
Other equity holders |
232 |
259 |
Equity holders of the parent |
2,096 |
1,809 |
Non-controlling interests |
2 |
3 |
Profit after tax |
2,098 |
1,812 |
|
|
|
Earnings per share |
|
|
Basic earnings per ordinary share |
13.0p |
10.3p |
|
|
|
Condensed consolidated balance sheet (unaudited) |
||
|
As at 31.03.25 |
As at 31.12.24 |
Assets |
£m |
£m |
Cash and balances at central banks |
239,481 |
210,184 |
Cash collateral and settlement balances |
158,754 |
119,843 |
Debt securities at amortised cost |
71,369 |
68,210 |
Loans and advances at amortised cost to banks |
9,409 |
8,327 |
Loans and advances at amortised cost to customers |
338,639 |
337,946 |
Reverse repurchase agreements and other similar secured lending at amortised cost |
8,084 |
4,734 |
Trading portfolio assets |
186,701 |
166,453 |
Financial assets at fair value through the income statement |
212,967 |
193,734 |
Derivative financial instruments |
255,062 |
293,530 |
Financial assets at fair value through other comprehensive income |
80,279 |
78,059 |
Investments in associates and joint ventures |
923 |
891 |
Goodwill and intangible assets |
8,250 |
8,275 |
Current tax assets |
196 |
155 |
Deferred tax assets |
5,917 |
6,321 |
Assets included in a disposal group classified as held for sale |
5,739 |
9,854 |
Other assets |
11,719 |
11,686 |
Total assets |
1,593,489 |
1,518,202 |
|
|
|
Liabilities |
|
|
Deposits at amortised cost from banks |
18,249 |
13,203 |
Deposits at amortised cost from customers |
556,060 |
547,460 |
Cash collateral and settlement balances |
145,439 |
106,229 |
Repurchase agreements and other similar secured borrowings at amortised cost |
34,262 |
39,415 |
Debt securities in issue |
97,525 |
92,402 |
Subordinated liabilities |
13,001 |
11,921 |
Trading portfolio liabilities |
70,503 |
56,908 |
Financial liabilities designated at fair value |
324,156 |
282,224 |
Derivative financial instruments |
245,386 |
279,415 |
Current tax liabilities |
896 |
566 |
Deferred tax liabilities |
18 |
18 |
Liabilities included in a disposal group classified as held for sale |
- |
3,726 |
Other liabilities |
12,454 |
12,234 |
Total liabilities |
1,517,949 |
1,445,721 |
|
|
|
Equity |
|
|
Called up share capital and share premium |
4,218 |
4,186 |
Other reserves |
(22) |
(468) |
Retained earnings |
57,421 |
56,028 |
Shareholders' equity attributable to ordinary shareholders of the parent |
61,617 |
59,746 |
Other equity instruments |
13,263 |
12,075 |
Total equity excluding non-controlling interests |
74,880 |
71,821 |
Non-controlling interests |
660 |
660 |
Total equity |
75,540 |
72,481 |
|
|
|
Total liabilities and equity |
1,593,489 |
1,518,202 |
Condensed consolidated statement of changes in equity (unaudited) |
|||||||
|
Called up share capital and share premium |
Other equity instruments |
Other reserves |
Retained earnings |
Total |
Non-controlling interests |
Total equity |
Three months ended 31.03.2025 |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
Balance as at 1 January 2025 |
4,186 |
12,075 |
(468) |
56,028 |
71,821 |
660 |
72,481 |
Profit after tax |
- |
232 |
- |
1,864 |
2,096 |
2 |
2,098 |
Retirement benefit remeasurements |
- |
- |
- |
(48) |
(48) |
- |
(48) |
Other comprehensive profit after tax for the period |
- |
- |
406 |
- |
406 |
- |
406 |
Total comprehensive income for the period |
- |
232 |
406 |
1,816 |
2,454 |
2 |
2,456 |
Employee share schemes and hedging thereof |
58 |
- |
- |
476 |
534 |
- |
534 |
Issue and redemption of other equity instruments |
- |
1,181 |
- |
- |
1,181 |
- |
1,181 |
Other equity instruments coupon paid |
- |
(232) |
- |
- |
(232) |
- |
(232) |
Vesting of employee share schemes net of purchases |
- |
- |
13 |
(562) |
(549) |
- |
(549) |
Dividends paid |
- |
- |
- |
- |
- |
(2) |
(2) |
Repurchase of shares |
(26) |
- |
26 |
(338) |
(338) |
- |
(338) |
Other movements |
- |
7 |
1 |
1 |
9 |
- |
9 |
Balance as at 31 March 2025 |
4,218 |
13,263 |
(22) |
57,421 |
74,880 |
660 |
75,540 |
|
As at 31.03.25 |
As at 31.12.24 |
Other Reserves |
£m |
£m |
Currency translation reserve |
3,079 |
3,625 |
Fair value through other comprehensive income reserve |
(1,640) |
(1,873) |
Cash flow hedging reserve |
(2,378) |
(2,930) |
Own credit reserve |
(891) |
(1,059) |
Other reserves and treasury shares |
1,808 |
1,769 |
Total |
(22) |
(468) |
|
|
|
Appendix: Non-IFRS Performance Measures
The Group's management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the financial statements, as they enable the reader to identify a more consistent basis for comparing the businesses' performance between financial periods, and provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.
However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as well.
Non-IFRS performance measures glossary
Measure |
Definition |
Loan: deposit ratio |
Total loans and advances at amortised cost divided by total deposits at amortised cost. |
Attributable profit |
Profit after tax attributable to ordinary shareholders of the parent. |
Period end tangible equity refers to: |
|
Period end tangible shareholders' equity (for Barclays Group) |
Shareholders' equity attributable to ordinary shareholders of the parent, adjusted for the deduction of goodwill and intangible assets. |
Period end allocated tangible equity (for businesses) |
Allocated tangible equity is calculated as 13.5% (2024: 13.5%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Barclays Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the Barclays Group's tangible shareholders' equity and the amounts allocated to businesses. |
Average tangible equity refers to: |
|
Average tangible shareholders' equity (for Barclays Group) |
Calculated as the average of the previous month's period end tangible shareholders' equity and the current month's period end tangible shareholders' equity. The average tangible shareholders' equity for the period is the average of the monthly averages within that period. |
Average allocated tangible equity (for businesses) |
Calculated as the average of the previous month's period end allocated tangible equity and the current month's period end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period. |
Return on tangible equity (RoTE) refers to: |
|
Return on average tangible shareholders' equity (for Barclays Group) |
Annualised Group attributable profit, as a proportion of average tangible shareholders' equity. The components of the calculation have been included on pages 42 to 43. |
Return on average allocated tangible equity (for businesses) |
Annualised business attributable profit, as a proportion of that business's average allocated tangible equity. The components of the calculation have been included on pages 42 to 44. |
|
|
Operating expenses excluding litigation and conduct |
A measure of total operating expenses excluding litigation and conduct charges. |
Operating costs |
A measure of total operating expenses excluding litigation and conduct charges and UK regulatory levies. |
Cost: income ratio |
Total operating expenses divided by total income. |
Loan loss rate |
Quoted in basis points and represents total impairment charges divided by total gross loans and advances held at amortised cost (including portfolios reclassified to assets held for sale) at the balance sheet date. The components of the calculation have been included on pages 45 to 47. |
Net interest margin |
Annualised net interest income divided by the sum of average customer assets. The components of the calculation have been included on page 24. |
Tangible net asset value per share |
Calculated by dividing shareholders' equity, excluding non-controlling interests and other equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The components of the calculation have been included on page 48. |
Profit before impairment |
Calculated by excluding credit impairment charges or releases from profit before tax. |
Structural cost actions |
Cost actions taken to improve future financial performance. |
Group net interest income excluding Barclays Investment Bank and Head Office |
A measure of Barclays Group net interest income, excluding the net interest income reported in Barclays Investment Bank and Head Office. |
Returns
|
Three months ended 31.03.25 |
|
|||||
|
Barclays UK |
Barclays UK Corporate Bank |
Barclays Private Bank and Wealth Management |
Barclays Investment Bank |
Barclays US Consumer Bank |
Head Office |
Barclays Group |
Return on average tangible equity |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
Attributable profit/(loss) |
510 |
142 |
96 |
1,199 |
41 |
(124) |
1,864 |
|
|
|
|
|
|
|
|
|
£bn |
£bn |
£bn |
£bn |
£bn |
£bn |
£bn |
Average equity |
15.7 |
3.3 |
1.2 |
29.6 |
4.2 |
7.4 |
61.4 |
Average goodwill and intangibles |
(4.0) |
- |
(0.1) |
- |
(0.6) |
(3.6) |
(8.3) |
Average tangible equity |
11.7 |
3.3 |
1.1 |
29.6 |
3.6 |
3.8 |
53.1 |
|
|
|
|
|
|
|
|
Return on average tangible equity |
17.4% |
17.1% |
34.5% |
16.2% |
4.5% |
n/m |
14.0% |
|
Three months ended 31.03.24 |
|
|||||
|
Barclays UK |
Barclays UK Corporate Bank |
Barclays Private Bank and Wealth Management |
Barclays Investment Bank |
Barclays US Consumer Bank |
Head Office |
Barclays Group |
Return on average tangible equity |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
Attributable profit/(loss) |
479 |
113 |
74 |
899 |
44 |
(59) |
1,550 |
|
|
|
|
|
|
|
|
|
£bn |
£bn |
£bn |
£bn |
£bn |
£bn |
£bn |
Average equity |
14.3 |
3.0 |
1.1 |
30.0 |
3.6 |
6.3 |
58.3 |
Average goodwill and intangibles |
(3.9) |
- |
(0.1) |
- |
(0.3) |
(3.5) |
(7.8) |
Average tangible equity |
10.4 |
3.0 |
1.0 |
30.0 |
3.3 |
2.8 |
50.5 |
|
|
|
|
|
|
|
|
Return on average tangible equity |
18.5% |
15.2% |
28.7% |
12.0% |
5.3% |
n/m |
12.3% |
|
|
|
|
|
|
|
|
Barclays Group |
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
|
Attributable profit/(loss) |
1,864 |
|
965 |
1,564 |
1,237 |
1,550 |
|
(111) |
1,274 |
1,328 |
|
|
|
|
|
|
|
|
|
|
|
|
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Average shareholders' equity |
61.4 |
|
59.7 |
59.1 |
57.7 |
58.3 |
|
57.1 |
55.1 |
55.4 |
Average goodwill and intangibles |
(8.3) |
|
(8.2) |
(8.1) |
(7.9) |
(7.8) |
|
(8.2) |
(8.6) |
(8.7) |
Average tangible shareholders' equity |
53.1 |
|
51.5 |
51.0 |
49.8 |
50.5 |
|
48.9 |
46.5 |
46.7 |
|
|
|
|
|
|
|
|
|
|
|
Return on average tangible shareholders' equity |
14.0% |
|
7.5% |
12.3% |
9.9% |
12.3% |
|
(0.9)% |
11.0% |
11.4% |
Barclays UK |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
|
Attributable profit |
510 |
|
781 |
621 |
584 |
479 |
|
382 |
531 |
534 |
|
|
|
|
|
|
|
|
|
|
|
|
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Average allocated equity |
15.7 |
|
15.1 |
14.5 |
14.4 |
14.3 |
|
14.1 |
14.0 |
14.2 |
Average goodwill and intangibles |
(4.0) |
|
(3.9) |
(3.9) |
(3.9) |
(3.9) |
|
(3.9) |
(3.9) |
(4.0) |
Average allocated tangible equity |
11.7 |
|
11.2 |
10.6 |
10.5 |
10.4 |
|
10.2 |
10.1 |
10.2 |
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
17.4% |
|
28.0% |
23.4% |
22.3% |
18.5% |
|
14.9% |
21.0% |
20.9% |
|
|
|
|
|
|
|
|
|
|
|
Barclays UK Corporate Bank |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
|
Attributable profit |
142 |
|
98 |
144 |
135 |
113 |
|
59 |
129 |
239 |
|
|
|
|
|
|
|
|
|
|
|
|
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Average allocated equity |
3.3 |
|
3.2 |
3.1 |
3.0 |
3.0 |
|
2.8 |
2.8 |
2.9 |
Average goodwill and intangibles |
- |
|
- |
- |
- |
- |
|
- |
- |
- |
Average allocated tangible equity |
3.3 |
|
3.2 |
3.1 |
3.0 |
3.0 |
|
2.8 |
2.8 |
2.9 |
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
17.1% |
|
12.3% |
18.8% |
18.0% |
15.2% |
|
8.4% |
18.3% |
32.9% |
Barclays Private Bank and Wealth Management |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
|
Attributable profit |
96 |
|
63 |
74 |
77 |
74 |
|
47 |
102 |
91 |
|
|
|
|
|
|
|
|
|
|
|
|
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Average allocated equity |
1.2 |
|
1.2 |
1.1 |
1.1 |
1.1 |
|
1.1 |
1.1 |
1.1 |
Average goodwill and intangibles |
(0.1) |
|
(0.1) |
(0.1) |
(0.1) |
(0.1) |
|
(0.1) |
(0.1) |
(0.1) |
Average allocated tangible equity |
1.1 |
|
1.1 |
1.0 |
1.0 |
1.0 |
|
1.0 |
1.0 |
1.0 |
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
34.5% |
|
23.9% |
29.0% |
30.8% |
28.7% |
|
19.1% |
41.2% |
35.9% |
Barclays Investment Bank |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
|
Attributable profit/(loss) |
1,199 |
|
247 |
652 |
715 |
899 |
|
(149) |
580 |
562 |
|
|
|
|
|
|
|
|
|
|
|
|
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Average allocated equity |
29.6 |
|
29.3 |
29.5 |
29.9 |
30.0 |
|
28.9 |
28.8 |
29.0 |
Average goodwill and intangibles |
- |
|
- |
- |
- |
- |
|
- |
- |
- |
Average allocated tangible equity |
29.6 |
|
29.3 |
29.5 |
29.9 |
30.0 |
|
28.9 |
28.8 |
29.0 |
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
16.2% |
|
3.4% |
8.8% |
9.6% |
12.0% |
|
(2.1)% |
8.0% |
7.7% |
|
|
|
|
|
|
|
|
|
|
|
Barclays US Consumer Bank |
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
|
Attributable profit/(loss) |
41 |
|
94 |
89 |
75 |
44 |
|
(3) |
3 |
72 |
|
|
|
|
|
|
|
|
|
|
|
|
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Average allocated equity |
4.2 |
|
4.0 |
3.8 |
3.6 |
3.6 |
|
3.6 |
3.8 |
3.9 |
Average goodwill and intangibles |
(0.6) |
|
(0.6) |
(0.5) |
(0.3) |
(0.3) |
|
(0.3) |
(0.7) |
(0.8) |
Average allocated tangible equity |
3.6 |
|
3.4 |
3.3 |
3.3 |
3.3 |
|
3.3 |
3.1 |
3.1 |
|
|
|
|
|
|
|
|
|
|
|
Return on average allocated tangible equity |
4.5% |
|
11.2% |
10.9% |
9.2% |
5.3% |
|
(0.3)% |
0.4% |
9.3% |
|
|
|
|
|
|
|
|
|
|
|
Loan loss rates
|
Three months ended 31.03.25 |
|
|||||
|
Barclays UK |
Barclays UK Corporate Bank |
Barclays Private Bank and Wealth Management |
Barclays Investment Bank |
Barclays US Consumer Bank |
Head Office |
Barclays Group |
Loan loss rate |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
Credit impairment charges |
(158) |
(19) |
9 |
(72) |
(399) |
(4) |
(643) |
|
|
|
|
|
|
|
|
|
£bn |
£bn |
£bn |
£bn |
£bn |
£bn |
£bn |
Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale)1 |
227.5 |
27.0 |
14.8 |
129.6 |
28.9 |
2.6 |
430.4 |
|
|
|
|
|
|
|
|
Loan loss rate (bps) |
28 |
28 |
(25) |
23 |
562 |
n/m |
61 |
|
Three months ended 31.03.24 |
|
|||||
|
Barclays UK |
Barclays UK Corporate Bank |
Barclays Private Bank and Wealth Management |
Barclays Investment Bank |
Barclays US Consumer Bank |
Head Office |
Barclays Group |
Loan loss rate |
£m |
£m |
£m |
£m |
£m |
£m |
£m |
Credit impairment charges |
(58) |
(15) |
- |
10 |
(410) |
(40) |
(513) |
|
|
|
|
|
|
|
|
|
£bn |
£bn |
£bn |
£bn |
£bn |
£bn |
£bn |
Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale)1 |
219.4 |
26.1 |
14.1 |
113.2 |
27.0 |
7.8 |
407.6 |
|
|
|
|
|
|
|
|
Loan loss rate (bps) |
11 |
23 |
- |
(4) |
610 |
n/m |
51 |
1 |
Includes gross loans and advances to customers and banks, in addition to debt securities. |
Barclays Group |
|
|
|
|
|
|
|
|
|
|
Loan loss rate |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
|
Credit impairment charges |
(643) |
|
(711) |
(374) |
(384) |
(513) |
|
(552) |
(433) |
(372) |
|
|
|
|
|
|
|
|
|
|
|
|
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale) |
430.4 |
|
429.6 |
408.3 |
409.1 |
407.6 |
|
409.3 |
411.2 |
407.0 |
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps) |
61 |
|
66 |
37 |
38 |
51 |
|
54 |
42 |
37 |
|
|
|
|
|
|
|
|
|
|
|
Barclays UK |
|
|
|
|
|
|
|
|
|
|
Loan loss rate |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
|
Credit impairment charges |
(158) |
|
(283) |
(16) |
(8) |
(58) |
|
(37) |
(59) |
(95) |
|
|
|
|
|
|
|
|
|
|
|
|
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale) |
227.5 |
|
227.5 |
218.4 |
217.3 |
219.4 |
|
223.3 |
225.7 |
227.7 |
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps) |
28 |
|
49 |
3 |
1 |
11 |
|
7 |
10 |
17 |
|
|
|
|
|
|
|
|
|
|
|
Barclays UK Corporate Bank |
|
|
|
|
|
|
|
|
|
|
Loan loss rate |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
|
Credit impairment charges |
(19) |
|
(40) |
(13) |
(8) |
(15) |
|
(18) |
(15) |
84 |
|
|
|
|
|
|
|
|
|
|
|
|
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale) |
27.0 |
|
25.8 |
25.2 |
26.0 |
26.1 |
|
26.6 |
27.2 |
27.2 |
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps) |
28 |
|
62 |
21 |
12 |
23 |
|
27 |
21 |
(123) |
|
|
|
|
|
|
|
|
|
|
|
Barclays Private Bank and Wealth Management |
|
|
|
|
|
|
|
|
|
|
Loan loss rate |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
|
Credit impairment charges |
9 |
|
(2) |
(7) |
3 |
- |
|
4 |
2 |
(7) |
|
|
|
|
|
|
|
|
|
|
|
|
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale) |
14.8 |
|
14.7 |
14.3 |
14.1 |
14.1 |
|
13.8 |
13.6 |
14.1 |
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps) |
(25) |
|
5 |
19 |
(9) |
- |
|
(10) |
(7) |
20 |
|
|
|
|
|
|
|
|
|
|
|
Barclays Investment Bank |
|
|
|
|
|
|
|
|
|
|
Loan loss rate |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
|
Credit impairment charge |
(72) |
|
(46) |
(43) |
(44) |
10 |
|
(23) |
23 |
(77) |
|
|
|
|
|
|
|
|
|
|
|
|
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale) |
129.6 |
|
124.9 |
116.5 |
115.5 |
113.2 |
|
109.4 |
108.6 |
103.7 |
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps) |
23 |
|
15 |
15 |
15 |
(4) |
|
8 |
(8) |
30 |
|
|
|
|
|
|
|
|
|
|
|
Barclays US Consumer Bank |
|
|
|
|
|
|
|
|
|
|
Loan loss rate |
Q125 |
|
Q424 |
Q324 |
Q224 |
Q124 |
|
Q423 |
Q323 |
Q223 |
£m |
|
£m |
£m |
£m |
£m |
|
£m |
£m |
£m |
|
Credit impairment charges |
(399) |
|
(298) |
(276) |
(309) |
(410) |
|
(449) |
(404) |
(264) |
|
|
|
|
|
|
|
|
|
|
|
|
£bn |
|
£bn |
£bn |
£bn |
£bn |
|
£bn |
£bn |
£bn |
Gross loans and advances held at amortised cost (including portfolios reclassified as held for sale) |
28.9 |
|
30.0 |
26.7 |
28.4 |
27.0 |
|
28.0 |
27.5 |
25.8 |
|
|
|
|
|
|
|
|
|
|
|
Loan loss rate (bps) |
562 |
|
395 |
411 |
438 |
610 |
|
636 |
582 |
411 |
|
|
|
|
|
|
|
|
|
|
|
Tangible net asset value per share |
As at 31.03.25 |
As at 31.12.24 |
As at 31.03.24 |
|
£m |
£m |
£m |
Total equity excluding non-controlling interests |
74,880 |
71,821 |
71,680 |
Other equity instruments |
(13,263) |
(12,075) |
(13,241) |
Goodwill and intangibles |
(8,250) |
(8,275) |
(7,813) |
Tangible shareholders' equity attributable to ordinary shareholders of the parent |
53,367 |
51,471 |
50,626 |
|
|
|
|
|
m |
m |
m |
Shares in issue |
14,336 |
14,420 |
15,091 |
|
|
|
|
|
p |
p |
p |
Tangible net asset value per share |
372 |
357 |
335 |
Shareholder Information
Results timetable1 |
|
|
|
|
|
Date |
|
||
2025 Interim Results Announcement |
|
|
|
|
|
29 July 2025 |
|
||
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
% Change3 |
|
|
|
|
|
Exchange rates2 |
31.03.25 |
31.12.24 |
31.03.24 |
31.12.24 |
31.03.24 |
|
|
|
|
Period end - USD/GBP |
1.29 |
1.25 |
1.26 |
3% |
2% |
|
|
|
|
3 month average - USD/GBP |
1.26 |
1.28 |
1.27 |
(2)% |
(1)% |
|
|
|
|
Period end - EUR/GBP |
1.19 |
1.21 |
1.17 |
(2)% |
2% |
|
|
|
|
3 month average - EUR/GBP |
1.20 |
1.20 |
1.17 |
-% |
3% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share price data |
|
|
|
|
|
|
|
|
|
Barclays PLC (p) |
287.80 |
268.15 |
183.20 |
|
|
|
|
|
|
Barclays PLC number of shares (m)4 |
14,336 |
14,420 |
15,091 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For further information please contact |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor relations |
Media relations |
|
|||||||
Marina Shchukina +44 (0) 20 7116 2526 |
Tom Hoskin +44 (0) 20 7116 4755 |
|
|||||||
|
|
|
|||||||
More information on Barclays can be found on our website: home.barclays |
|
||||||||
|
|
|
|
|
|
|
|
|
|
Registered office |
|
|
|
|
|
|
|
|
|
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839. |
|
||||||||
|
|
|
|
|
|
|
|
|
|
Registrar |
|
|
|
|
|
|
|
|
|
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom. |
|
||||||||
Tel: +44 (0)371 384 2055 (UK and International telephone number)5. |
|
||||||||
|
|
|
|
|
|
|
|
|
|
American Depositary Receipts (ADRs) |
|
|
|
|
|
|
|
|
|
Shareowner Services |
|
||||||||
P.O. Box 64504 |
|
||||||||
St. Paul, MN 55164-0504 |
|
||||||||
United States of America |
|
||||||||
shareowneronline.com |
|
|
|
|
|||||
Toll Free Number (US and Canada): +1 800-990-1135 |
|
|
|
|
|
||||
Outside the US and Canada: +1 651-453-2128 |
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
Delivery of ADR certificates and overnight mail |
|
|
|
|
|
|
|
|
|
Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120-4100, USA. |
|
1 |
Note that this date is provisional and subject to change. |
2 |
The average rates shown above are derived from daily spot rates during the year. |
3 |
The change is the impact to GBP reported information. |
4 |
The number of shares of 14,336m as at 31 March 2025 is different from the 14,328m quoted in the 1 April 2025 announcement entitled "Total Voting Rights" because the share buyback transactions executed on 28 and 31 March 2025 did not settle until 1 and 2 April 2025 respectively. |
5 |
Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales. |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.